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Anorexia nervosa (AN) is a disorder recognized by underweight and psychiatric symptoms, and 
some patients are at risk of developing refeeding syndrome (RFS). AN patients may experience 
metabolic disturbances and severe symptoms during refeeding, and international guidelines in 
how to refeed AN patients at risk of RFS varies. The regional departments of eating disorders 
(EDs) in Norway treat about 100-200 patients every year with AN, and a survey investigating 
procedures have not been performed before.   
 
Aim 
This master thesis has investigated how physicians and registered dietitians (RDs) in the 
departments of EDs in Norway consider RFS, and how they  refeed and monitor patients with 
AN. Due to the complications and problems that may occur during refeeding in high-risk groups 
like AN, it was of interest to investigate if procedures, knowledge and awareness varied between 
the ED units and if the basic reference menu at RASP contain the energy and micronutrients that 
is recommended for AN patients during refeeding. 
 
Method 
Procedures, questionnaires and analysis of the basic reference menu at RASP have been collected 
and analyzed. The procedures were collected by contacting the head physicians at the different 
regional departments of EDs by mail. The master student designed the questionnaire, with 
assistance from the RDs and supervisor at RASP. The four-week rollover dinner menu at RASP 
was weighed, photographed and nutritional content calculated. The average nutrient content of 
the dinners was analyzed together with the other meals (breakfast, lunch, and evening meal) in 
the basic menu/ and half of the basic menu to evaluate the yield of important nutrients trough one 
day.   
 
Results 
Three out of six regional departments of EDs have a procedure to identify and/or treat patients at 
risk of RFS. Initial refeeding range of energy in the procedures varied between 10-30 




units. Only one clinician at one of the ED units had ever seen a patient with full-blown RFS. The 
basic reference menu at RASP covers the recommendations of most nutrients. Half basic 
reference menu contains more energy than most international guidelines recommended for 
patients at risk of RFS. The energy contents in dinner portions in the basic reference menu 
contain an average of about 480kcal.  
 
Conclusion 
The procedures of RFS vary between the regional departments of EDs in Norway. A closer 
collaboration between the units may be favorable, and all units ought to have procedures to 
identify and treat patients at risk of RFS. The knowledge and awareness of RFS among 
physicians and RDs working at an ED unit in Norway are good. However, the questionnaire 
detected that there are some uncertainties both among the physicians and RDs about the 
definition of RFS.  
 
The energy prescribed in “Halv grunnmeny” is higher than most of the international guidelines 
for initial refeeding of patients at risk of RFS. The basic reference menu makes an important 
frame for and is a good guidance for the milieu therapists that serve the patients during the 
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2.3 DPG   2.3 diphosphoglycerate 
AN    Anorexia nervosa 
APA   American Psychiatric Association 
ATP    Adenosine triphosphate 
BMI    Body mass index, kg/m² 
BMR    Basal metabolic rate 
BN    Bulimia nervosa 
Clˉ   Chloride 
ED   Eating disorder 
EN    Enteral nutrition 
ESPEN  European Society for Clinical Nutrition and Metabolism  
IBW   Ideal body weight 
IrSPEN  The Irish Society for Clinical Nutrition and Metabolism 
IM   Intramuscular 
K+   Potassium 
Kcal    Kilocalorie 
Na+   Sodium 
NICE   The National Institute for Health and Clinical Excellence 
Mg²+   Magnesium 
MARSIPAN  Management of Really Sick Patients with Anorexia Nervosa  
PN    Parenteral nutrition 
RASP  Regional seksjon spiseforstyrrelser (Oslo) (English: Regional Department 
of Eating Disorders) 
RD    Registered dietician  
RESSP   Regionalt senter for spiseforstyrrelser (Bodø) 
RFS    Refeeding syndrome 
RKSF   Regionalt kompetansesenter for spiseforstyrrelser (Stjørdal/Levanger) 
















Anabolic   Energy requiring processes 
Catabolic    Energy releasing processes 
Enteral nutrition  In this thesis, enteral nutrition is used to describe tube feeding 
exclusively (not food or nutritional drinks).  
“Grunnmeny” The basic reference menu at RASP (2650 kcal) 
Incidence  Number of new cases in a population over a specific period 
“Halv grunnmeny” About half the basic reference menu at RASP (1350/1400 kcal).  
Parenteral nutrition   Nutrition given intravenously 
Prevalence    Total number of cases in a population 
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Eating disorders (EDs) is a group of disorders that is characterized by disturbed eating and body 
image. The most well-known diagnoses are anorexia nervosa (AN) and bulimia nervosa (BN), 
but the largest group of patients with EDs is found in the diagnosis eating disorders not otherwise 
specified (EDNOS) (Smink, van Hoeken, & Hoek, 2012). Only a description of AN will be given 
in this thesis. AN is an ED with severe psychiatric symptoms, as well as a disturbed body image, 
underweight and malnourishment (Gentile, Pastorelli, Ciceri, Manna, & Collimedaglia, 2010; 
Zipfel, Giel, Bulik, Hay, & Schmidt, 2015). A further description of AN is given in chapter 2.2.  
 
Refeeding syndrome (RFS), a condition recognised by metabolic disturbances during refeeding 
of severely underweight or starved patients, has been known for decades (H. Mehanna, 
Nankivell, Moledina, & Travis, 2009). Even though RFS is well known, a common global 
definition is lacking, and the awareness of this syndrome in patients with AN among health 
personnel varies (M. A. Crook, 2014). There is also a lack of information about how the health 
personnel judge the severity of this condition. A question that has been raised is whether the 
concern or awareness of RFS is appropriate during treatment of patients with AN or whether the 
concern in patients with AN is exaggerated. 
 
The different regional departments of EDs in Norway treat about 100-200 patients each year with 
AN (personal communication Rø, Ø 2016), and AN patients is the most common patient group at 
the regional department of ED in Norway. A key component in the treatment of these patients is 
nutritional rehabilitation and reduction of underweight (Gentile et al., 2010). Treatment of AN 
and other EDs and the severity of EDs have lately generated a surge of interest in the media. How 
these patients are treated in Norway and what the procedures of the treatment given due to the 
concern of RFS are topics that have not been evaluated before.    
 
1.1  Objectives/aims 
 
Due to the severity of AN and risk of developing RFS it seems important to figure out whether a 
common practice exists among the regional departments of EDs in Norway to detect and prevent 




high-risk groups like AN, it has been of interest to investigate if procedures, knowledge and 
awareness varies between the regional departments of EDs, and if the basic reference menu at 
RASP contains the energy and micronutrients that is recommended for this patient group during 
the refeeding phase of the treatment.  
 
1.2  Research questions  
 
1. Do procedures exist to identify, treat and monitor patients in risk of developing RFS in 
regional departments of EDs in Norway? Do the procedures correspond to international 
guidelines? 
 
2. How is the experience and knowledge about RFS among physicians and RDs working at 
the departments of EDs in Norway? 
 
3. Does the half basic reference menu (“Halv grunnmeny”) developed by RDs at RASP 
cover the electrolyte and energy recommendations given for the refeeding phase (first 2-3 




In the following chapters, background information about RFS and AN will be given. Regarding 
RFS, a historical background will be presented, as well as a short description of the mechanism, 
definitions, incidences and risk groups. The background information about AN includes 
diagnostic criteria, incidence and prevalence, pathogenesis, health consequences and treatment. 
Guidelines for refeeding AN patients and patients at risk of RFS are then described.  
 
Considering risk and treatment of RFS, both procedures for AN adolescents and adults have been 
investigated. When available, guidelines for both groups are presented and discussed, but 
unfortunately, the literature in this field does not always distinguish between the age groups. If 




2.1 Refeeding syndrome 
2.1.1 History  
 
Refeeding syndrome was first observed during and after World War 2 (Fuentebella & Kerner, 
2009). Observations in Leningrad, the famine in Netherlands, the Minnesota semi-starvation 
experiment and refeeding of starved prisoners in Japan, are all examples of situations where they 
observed cardiac insufficiency, oedema, high blood pressure and neurological complications 
during refeeding (Fuentebella & Kerner, 2009; Kraft, Btaiche, & Sacks, 2005; Miller, 2008).  
 
In the Minnesota semi-starvation experiment from 1944-45 the patients experienced early signs 
and symptoms of heart failure after intake of high calorie diets after six months of semi-starvation 
(Brozek, Chapman, & Keys, 1948). In the semi-starvation period, they were given 1600 kcal and 
49 grams of protein for six months after a three-month long observation, resulting in an average 
weight loss of 23.9 %. When they started refeeding after six months, complications that may be 
known as symptoms of RFS today occurred (Brozek et al., 1948). 
 
In a Japanese study from 1945, previously starved prisoners were refed and developed severe 
symptoms (M. A. Crook, 2014). They were given high calorie diets, and were supplemented with 
yeast, thiamine chloride and ferrous sulphate (Maurice A. Schnitker, Paul E. Mattman, & 
Theodore L. Bliss, 1951). It was estimated that the patients’ diets consisted of 800-1000 kcal 
during semi-starvation, and the prisoners had lost 40 % of their normal body weight. They 
developed severe symptoms like neuropathy and oedemas; symptoms associated with RFS, and 
21 % of them died (M. A. Schnitker, P. E. Mattman, & T. L. Bliss, 1951).   
 
Even though the knowledge about the possible consequences of refeeding has been known since 
the World War 2, the term RFS was first used by Weinsier and Krumdieck in 1981 (Boateng, 
Sriram, Meguid, & Crook, 2010). Two severely malnourished patients (40 and 70 % of ideal 
body weight (IBW)) died after they were given carbohydrates 21-23 g/kg/day and protein 3.5 
g/kg/day in total parenteral nutrition (PN) (Weinsier & Krumdieck, 1981).  
The introduction of enteral nutrition (EN) and PN have given health personnel the opportunity to 
refeed patients more aggressively (Kraft et al., 2005), but the risk of developing RFS may be 




2.1.2 Mechanisms of refeeding syndrome 
 
RFS, also called nutritional recovery syndrome (Klein, Stanek, & Wiles, 1998), is recognized by 
shifts in electrolytes and fluids due to changes in hormonal and metabolic systems during 
starvation and refeeding (H. M. Mehanna, Moledina, & Travis, 2008). The main finding is 
hypophosphatemia, but also levels of other electrolytes, especially potassium and magnesium 
(Golden, Keane-Miller, Sainani, & Kapphahn, 2013), vitamins (especially thiamine) and trace 
elements may be low (Boateng et al., 2010; Golden et al., 2013; Sobotka, 2010). The symptoms 
of RFS are generally expected to be observed within 3-10 days after refeeding has started (Hofer 
et al., 2014). A summary of deficiencies, organ systems and symptoms involved in RFS are 




During starvation, or semi-starvation, the body has to use already stored energy. The body tries to 
compensate for the lack of ingested energy by means of changes in metabolism from an anabolic 
state to a catabolic state (M. A. Crook, 2014). Due to the depletion of glycogen stores during 
starvation (within 24-72 hours) (Kraft et al., 2005), the muscles release amino acids and the 
adipose tissue release free fatty acids and glycerol to compensate for the low calorie intake. This 
utilization of fat and protein provides glucose through gluconeogenesis and ketones, which will 
make a decrease in lean body mass if starvation is persistent (M. A. Crook, 2014).  
 
Insulin levels decrease, while glucagon levels increase during starvation. Muscles and other 
tissues decrease their use of ketone bodies, resulting in an increase of ketone levels in blood. This 
increase result in an increased use of ketone bodies compared to glucose in the brain (H. M. 
Mehanna et al., 2008). In this way, the body reduces the mobilization of proteins from other 
tissues, and save the body stores. The liver decreases its gluconeogenesis when the body adapt to 
ketone production, and the metabolism decreases due to decreased oxygen consumption, reduced 
muscle activity and reduced body temperature in a fasting state (Kraft et al., 2005). 
 
Macromolecules, as well as the body’s storage of electrolytes, are depleted during starvation, and 




plasma levels of ions, as expressed through blood samples, are surprisingly normal even though 
intracellular body stores are markedly decreased (H. M. Mehanna et al., 2008). Physiological 
adaptations to ensure satisfying plasma levels include increased renal tubular reabsorption of 
phosphate, potassium and calcium, tissue and bone breakdown, and dehydration, which may 




Figure 1 Mechanisms of possible consequences of refeeding after starvation  
 
Retrieved from “Nutrition in clinical practice-the refeeding syndrome: illustrative cases and guidelines for prevention 
and treatment” Stanga et al (2008). 
 
When refeeding is started after a starvation period, the body shifts from a catabolic state back to 
an anabolic state (H. Mehanna et al., 2009). Carbohydrates, or glucose, become the primary 
source of energy, resulting in a shift in insulin and glucagon secretion. This shift causes a high 
demand of intermediates in glycolysis, like phosphate and thiamine, due to the production of 
phosphorylated adenosine triphosphate (ATP) and 2.3 diphosphoglycerate (2.3 DPG) 
(Fuentebella & Kerner, 2009; Kraft et al., 2005). ATP is a coenzyme used by the cells in our 
body, and 2.3DPG have an important role in promoting release of oxygen from haemoglobin 
(Solomon & Kirby, 1990). The shift in metabolism increase the usage and production of these 




increased, and plasma levels of these electrolytes could drop rapidly (M. Crook, Hally, & Panteli, 
2001; M. A. Crook, 2014).  
Electrolytes, vitamins and fluid 
 
To make a proper understanding of what may happen in RFS, a description of the main ions that 
are involved and which role they have in the body is given below.  
 
Table 1 Deficiencies, organ systems and symptoms that may be involved in RFS 
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Hyperglycaemia Hypotension Hypercapnia 
Failure 
 






(Kraft et al., 2005) 
 
Hypophosphatemia Phosphorus is the major intracellular anion in our body, and 85 % of 
phosphorus in humans is found in bone, and 15 % circulating in soft tissues like blood and 
extracellular fluid (Skipper, 2012). During starvation the body stores of this electrolyte is 
decreased. Fat metabolism during starvation does not utilize ATP (Ornstein, Golden, Jacobson, & 




increase rapidly, as described in the paragraph above. The resulting low phosphorus levels are 
mainly a consequence of increased insulin excretion due to elevated glucose content of the food 
during refeeding (Mehler, Winkelman, Andersen, & Gaudiani, 2010). The electrolyte 
abnormalities are most often observed during the first five days of refeeding (M. Crook et al., 
2001). The clinical signs of hypophosphatemia are listed in table 1.  
 
The normal range of serum phosphate is 0.85-1.4 mmol/L. Hypophosphatemia is normally 
asymptomatic for levels > 0.64 mmol/L (Elektrolyttveilederen, 2014). Low serum levels of 
phosphorus are in most of the literature defined as < 0.80 mmol/L, mild hypophosphatemia as 
0.50 mmol/L and severe hypophosphatemia as < 0.30 mmol/L (M. A. Crook, 2014), but the cut-
offs may vary.  
 
Table 2 Cut-off values for hypophosphatemia in different sexes and ages 
Cut-off values, 
hypophosphatemia, mmol/L 
Women Men Adolescents 13-17 
0.89 0.79 0.90 
(Elektrolyttveilederen, 2014; Unilabs Laboratoriemedisin, 2016).  
Hypokalaemia Potassium is the major intracellular cation (98 % of the potassium in our body is 
in the intracellular space, but there are also some in bones and cartilage) (Kraft et al., 2005). 
Potassium is essential for maintaining cell membrane action potential. This membrane action 
potential is disturbed when the body’s potassium stores are depleted, which in turn may result in 
symptoms as presented in table 1. Severe hypokalaemia is defined as serum levels < 3 mmol/L, 
and at this level, symptoms normally will occur (Elektrolyttveilederen, 2014).  
 
Potassium levels are often decreased in patients with BN and purging type of AN (described 
further in chapter 3.2), due to vomiting and use of diuretics and laxatives (Mehler & Rylander, 
2015). There is an up regulation of the rennin-angiotensin-aldosterone steroid hormone system if 
laxative abuse or vomiting is present due to dehydration (Mehler & Rylander, 2015). The up 
regulation will increase renal absorption of sodium, water and bicarbonate, and at the same time 
increase the excretion of potassium to maintain electrochemical balance (Mehler & Rylander, 
2015). A further description of this mechanism will not be given here, but when dealing with this 
patient group, the severity of the disease and potassium levels should be taken into consideration 




Hypomagnesaemia Magnesium is mostly found in bone, muscle and soft tissue, and is the 
second most abundant cation in our body. Only 1 % of the magnesium is stored in the extra 
cellular fluid (Kraft et al., 2005).  Serum levels of < 0.5 mmol is defined as hypophosphatemia 
(Elektrolyttveilederen, 2014). Magnesium is important for optimal cell function, and is a cofactor 
in many enzymes. Magnesium is an important structure of DNA, RNA and ribosomes, and the 
demand for magnesium increases when metabolism increases (Fuentebella & Kerner, 2009). 
Symptoms of hypomagnesaemia are presented in table 1.  
 
Magnesium and potassium levels are linked, because they in many cases act as antagonists. 
Hypomagnesaemia could cause hypokalaemia because of this linkage (Kraft et al., 2005; H. 
Mehanna et al., 2009). Magnesium is also an important component of the Na+/K+-pump, as a 
cofactor of the enzyme ATPase in the cells, and therefore a depletion of magnesium could affect 
potassium repletion (Fuentebella & Kerner, 2009; Kraft et al., 2005).  
 
Figure 2 Magnesium’s contribution as a co-factor in ATPase 
 
Retrieved from “Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited”  
Borkowski, Cheema, Shahbaz, Bhattacharya, & Weber (2011) 
 
Hypomagnesaemia could contribute to hypocalcaemia due to decreased release or activity of 
parathyroid hormones (Kraft et al., 2005). Adequate magnesium levels are also required for the 
active form of thiamine, because of magnesium’s role as a co-factor in the enzyme transketolase 




Thiamine Vitamin B1 is an important vitamin and coenzyme in carbohydrate metabolism (H. 
Mehanna et al., 2009), so if refeeding (of carbohydrates) is started too rapid, the enzyme will be 
depleted and Korsakoff`s syndrome and Wernicke`s encephalopathy may occur. It is important to 
remember that water retention during refeeding is not always caused by vitamin B1 deficiency, 
but could be due to increased insulin secretion and fluctuation of water into the cells. Korsakoff`s 
syndrome is recognised by amnesia and confabulation while Wernicke`s encephalopathy is 
characterized by ataxia, confusion, hypothermia, ocular abnormalities and coma (Fuentebella & 
Kerner, 2009). Thiamine is rapidly used during glycolysis, and low levels impair glucose 
metabolism and may lead to lactic acidosis (Fuentebella & Kerner, 2009).  
 
Depletion of thiamine is one of the symptoms of RFS (Gentile et al., 2010), and the body stores 
could be depleted quickly with malnutrition and underweight. The half-life of thiamine is 
approximately 9.5 to 18.5 days (McCray, Walker, & Parrish, 2005). Deficiency could occur after 
less than 28 days of malnutrition (Fuentebella & Kerner, 2009). The requirements of thiamine are 
related to energy and carbohydrate intake, due to thiamine’s role in thiamine pyrophosphate, 
which is essential in metabolism of glucose (McCray et al., 2005). The table below shows 
recommended intake for women, men and children. 
 
Table 3 Recommended intake of thiamine, mg/d  
 Women Men Children 10-13y 
girls/boys 
Recommended intake, mg/day 1.1 1.4 1.0/1.2 
Average requirement, mg/day 0.9 1.2  
(Nordic Nutrition Recommendations, 2012) 
 
Salt and water Rapid carbohydrate refeeding decrease the excretion of sodium and water by the 
kidneys (H. Mehanna et al., 2009) due to increased insulin excretion. This results in expanded 
extra cellular fluid and weight gain (due to fluids), and fluid levels should be monitored closely 
when refeeding malnourished patients. Fluid and sodium overload may be shown as oedemas, 
congestive cardiac failure and fluid overload (Fuentebella & Kerner, 2009). A low sodium diet is 





High protein diets may result in high sodium levels, due to metabolic acidosis, azotaemia or 
dehydration (M. Crook et al., 2001). Patients at risk of RFS are at risk of renal abnormalities, and 
should be monitored regarding renal function during refeeding, especially if protein intake is high 
or the patient struggle to meet the fluid requirements (M. A. Crook, 2014).  
 
2.1.3 Diagnostic criteria  
 
Some authors have tried to define the diagnostic criteria for RFS and to explain the syndrome 
(Solomon & Kirby, 1990). Hofer et.al (2014) have three facets that have to be met to diagnose a 
patient with RFS (figure 3).  
 
Figure 3 Diagnostic criteria of RFS  
 
Retrieved from “Safe refeeding management of anorexia nervosa inpatients: an evidence-based protocol” Hofer et al. 
(2014). 
 
The authors point out that symptoms may be non-specific and difficult to assess, thus making a 
common definition problematic (M. A. Crook, 2014; Fuentebella & Kerner, 2009; H. Mehanna et 
al., 2009). Well-nourished patients may also experience a minor fall in electrolytes with refeeding 
only after a few days of starvation, but not have any clinical symptoms (Stanga et al., 2008). This 
complicates the diagnosis, and confirms that unusual lab-values itself is not synonymous with 
RFS (Stanga et al., 2008).  The word syndrome implies multiple symptoms and abnormalities, 




(Skipper, 2012). The duration of the starvation period before RFS may occur is varying, but 
hypophosphatemia induced symptoms, which is a contributor of RFS, may be developed only 
after 48 hours of starvation (Marik & Bedigian, 1996). 
 
The ICD-10 diagnosis classification does not have a specific diagnose for RFS (World Health 
Organization, 1992), making this syndrome both difficult to detect and to research.  
 
The true incidence of RFS is unknown and the studies investigating the incidence have different 
numbers of cases dependent on wards and diseases (Owers et al., 2015), and due to different 
diagnostic criteria used. The estimated incidence varies between 0.43 % to 34 % in different 
hospital populations (M. A. Crook, 2014). Hofer et al. (2014) investigated complications during 
refeeding in a retrospective observational study of AN patients, and found that 10.5 % developed 
symptoms like oedemas, organ dysfunction and hypokalaemia, but none of them developed RFS.  
A similar result was found by Vignaud et al. (2010) were 10 % of AN patients admitted to an 
intensive care unit developed metabolic, haematological, hepatic, and infectious events, but not 
RFS. 
 
The incidence of refeeding hypophosphatemia, often used as a surrogate for RFS, in AN patients 
vary from 0 % to 45 % in different studies (Kameoka et al., 2015).  
 
2.1.4 Patients at risk 
 
The National Institute for Health and Clinical Excellence (NICE) have developed some criteria to 
identify patients at risk of RFS (table 4). The NICE-guidelines are only level D 
recommendations, which means that the recommendations are based on evidence from expert 
committees, case reports and clinical experience from respected authorities, and are not 
necessarily rooted in research, but are still the recommendation that is found in most literature (H. 









Table 4 NICE guidelines to identify patients at risk of RFS 
The patient has either one or more of the following 
- Body mass index (kg/m2) < 16 
- Unintentional weight loss > 15 % in the past three to six months 
- Little or no nutritional intake for > 10 days 
- Low levels of potassium, phosphate, or magnesium before feeding 
Or the patient has two or more of the following: 
- Body mass index < 18.5 
- Unintentional weight loss > 10 % in the past three to six months 
- Little or no nutritional intake for > 5 days 
- History of alcohol misuse or drugs, including insulin, chemotherapy, antacids, or 
diuretics 
(National Institute for Health and Clinical Excellence, 2006) 
 
What the guideline define as “little nutritional intake” is not described. In addition to the NICE 
guidelines, other authors have made guidelines or suggestions to identify patients at risk of RFS 
(Stanga et al., 2008). 
 
Table 5 Patients at risk of developing RFS  
Low nutrient intake 
- Patients starved for > 7 days 
- Prolonged hypocaloric feeding and fasting 
- Chronic swallowing problems and other neurological disorders 
- Anorexia nervosa 
- Chronic alcoholism 
- Depression in the elderly 
- Patients with cancer 
- Chronic infectious diseases 
- During convalescence from catabolic illness 
- Postoperative patients 
- Diabetic hyperosmolar states 




- Homelessness, social deprivation 
- Idiosyncratic/eccentric diets 
- Hunger strikes 
Increased nutrient losses/decreased nutrient absorption 
- Significant vomiting and/or diarrhoea 
- Dysfunction or inflammation of the gastrointestinal tract 
- Chronic pancreatitis 
- Chronic antacid users (these bind minerals) 
- Chronic high-dose diuretic diets 
- After bariatric surgery 
























2.2  Anorexia nervosa 
 
AN can be divided into two distinct sub-types; restrictive and binge-purge subtype (Hofer et al., 
2014). The restrictive type is characterized by an extreme reduction of food intake, while the 
binge-purging subtype also includes episodes of bingeing and purging (Meczekalski, Podfigurna-
Stopa, & Katulski, 2013), like vomiting, diuretic or laxative abuse (Mehler & Rylander, 2015). 
 
2.2.1 Diagnostic criteria 
 
The official diagnostic system in Norway is ICD-10 (ICD-10 diagnostic criteria for AN are 
presented in table 7, but there are also other diagnostic criteria that are used in the literature 
(Diagnostic and Statistical Manual of Mental Disorders (DSM) IV and 5 (Zipfel et al., 2015)).  
 
The ICD-10 criteria are currently under revision, and an updated version (ICD-11) is in progress 
(Zipfel et al., 2015). ICD-10 has both a version used in research and a version used by clinicians, 
and the one used in research are presented below.  
 
Table 7 ICD-10 criteria to diagnose patients with AN  
A. Weight loss, or in children a lack of weight gain, leading to a body weight of at least 
15 % below the normal or expected weight for age and height. 
B. The weight loss is self-induced by avoidance of “fattening foods”. 
C. A self-perception of being too fat, with an intrusive dread of fatness, which leads to a 
self-imposed low weight threshold.  
D. A widespread endocrine disorder involving the hypothalamic-pituitary-gonadal axis, 
manifest in the female as amenorrhoea and in the male as a loss of sexual interest and 
potency (an apparent exception is the persistence of vaginal bleeds in anorexic women 
who are on replacement hormonal therapy, most commonly taken as a contraceptive 
pill). 
E. Does not meet criteria A and B of bulimia nervosa. 




2.2.2 Incidence and prevalence 
 
Hoek (2006) found that incidence rates of AN in different studies varied from 4.2-8.3 per 
100 000 person, and that 40 % of all AN cases are in the age group 15-19 years. The incidence 
rate in this group has also increased in the last decades (Smink et al., 2012), but it is unclear if 
this is due to earlier detection, earlier onset of the disease, or due to earlier menarche and puberty 
(Favaro, Caregaro, Tenconi, Bosello, & Santonastaso, 2009).  
 
The lifetime prevalence of AN in females is estimated to be between 0.3-2.2 % (Smink et al., 
2012). The lifetime prevalence in men is lower, about 0.24 %, but may be underestimated 
(Meczekalski et al., 2013). The prevalence of the other EDs is higher than for AN (Hoek, 2006). 
In Norway, this estimate means that about 50 000 women are affected by an ED, and of these 
2700 women have AN, 18 000 women have BN and 28 000 women have BED (Rosenvinge JH, 
2002). These are numbers are only an estimate based on numbers from other countries. 
 
The average age of onset for AN is 17.4 years in females and 18.1 years in males (Favaro et al., 
2009), and few new cases occur after age 25 (Favaro et al., 2009). It is also noteworthy that less 
than 50 % of those having an ED are identified in primary care (Bjørnelv, 2004), and less than 50 




The pathogenesis of AN is complex and will differ between every patient, but there are certain 
factors that often are present. AN seems to be more common in some families, which are due to 
both genetic (28-74 %) and social factors (Zipfel et al., 2015). Developmental and personal 
factors that may contribute are prematurity, sleeping and feeding difficulties in infancy, 
depression, perfectionism, emotional liability, autism and anxiety (Zipfel et al. 2015). The onset 
commonly observed in puberty may be due to hormonal changes and dysregulations that interact 
with neurotransmitter functioning (Zipfel et al., 2015).  Strict dieting and excessive exercise are 
risk factors for AN. Female gender is by itself a risk factor of developing AN. Sexual or physical 




It has been investigated whether neurological abnormalities could be a predictor of AN, but most 
studies have looked at already ill or recovered patients, and these abnormalities could be changes 
due to malnourishment (Zipfel et al., 2015).  
 
There is also a socio-cultural risk factor for developing EDs. AN is found across different 
cultures, but studies have found higher prevalence in western cultures (Pilecki, Salapa, & Jozefik, 
2016). There is a perceived pressure to be thin and to have a body applicable to the standards set 
in a western society, which again is a causal risk factor for dieting, body dissatisfaction and fear 
of weight gain, all factors that can trigger an ED. The drive for thinness is amplified by mass 
media, which idealizes certain body types and influences the attention to our own body 
negatively (Pilecki et al., 2016). 
 
2.2.4 Adverse health effects 
 
A disturbed body image, an intense fear of weight gain and restricted food intake are all 
symptoms that are present in a patient with AN, as well as extreme underweight (< 85 % of 
IBW). Excessive physical activity and purging are also common (Zipfel et al., 2015). Very often, 
these patients have medical and psychiatric comorbidities (Meczekalski et al., 2013), and 
emotional and cognitive functioning is disturbed. Depression is the most common psychiatric 
comorbidity, with a rate of 40-45 % (Meczekalski et al., 2013); highest among adults and higher 
among the binge-purging type of AN than the restricted type (Halmi, 2003). Other common 
comorbidities are anxiety disorders, substance use, social phobia and post-traumatic stress 
disorder (Meczekalski et al., 2013).  
 
Somatic complications are common, and all organ systems may be affected. Cardiac problems 
may occur because of the structural, functional and electrocardiological changes, and the 
incidence may be as high as 87 % in the most severe cases (BMI< 15) of AN patients 
(Meczekalski et al., 2013; Norrington, Stanley, Tremlett, & Birrell, 2012). The gastric wall 
circulation is disturbed, and necrosis may occur (Meczekalski et al., 2013). Gastric emptying is 
significantly delayed in patients with AN (Norris et al., 2015), and many patients complain about 
feeling of fullness after ingested meals. The situation is worsened with longer time span of the 




cells, white blood cells and platelets (Mehler & Brown, 2015). Reductions in grey and white 
matter have been observed in underweight AN patients, but these changes will probably recover 
with weight gain (Boateng et al., 2010; Zipfel et al., 2015). A summary of signs and symptoms 
are presented in table 6. 
 
Table 6 Signs and symptoms that may occur in patients with AN  




- Prolonged Qt-interval 
- Arrhythmias 
- Hypoglycaemia 
- Poor metabolic control in 












Gastrointestinal Skin/bone Others 
- Severe acute pancreatitis 
- Parotid and salivary 
gland hypertrophy 
- Reduced gastric motility 
and early satiety 
- Mallory-weiss tears, 
ruptures 
- Esophagitis 
- Raised liver enzymes 
and low albumin 
- Osteopenia/osteoporosis, 
stress fractures 
- Reduced height growth 
- Brittle hair, hair loss, 
lanugo hair 







- Erosions and 
perimylolysis (if vomiting) 
(Meczekalski et al., 2013; Mehler & Brown, 2015) 
 
The basal metabolic rate (BMR) may be reduced with as much as 20-25 % (H. Mehanna et al., 
2009; H. M. Mehanna et al., 2008). Most studies find that this is due to both the lower fat mass 
and fat free mass in AN patients than controls, while a few studies also find that the decrease in 
BMR is even lower than expected when looking at body mass in AN patients (de Zwaan, Aslam, 




Patients in this group have an increased mortality rate (six times higher) compared to a healthy 
population (Meczekalski et al., 2013) and have the highest mortality rate compared to other 
psychiatric disorders (Davenport, Rushford, Soon, & McDermott, 2015; Meczekalski et al., 
2013). The mortality rate is higher in older patients, which could be explained by that older 
patients have a longer duration of illness, and hence an advanced stage of comorbidities and 
somatic complications (Ackard, Richter, Egan, & Cronemeyer, 2014). The longer patients have 
had AN, the less effective the treatment will be due to the chronicity of the disease (Davenport et 
al., 2015). 
 
One in 5 deaths, or 20 %, is due to suicide in this patient group, independent of age (Meczekalski 
et al., 2013). Most of deaths are caused by medical complications due to starvation and 
malnutrition (Zipfel et al., 2015). Due to these complications mentioned, patients with a weight 
less than 30 % of ideal body weight (IBW) are normally encouraged to be treated in a hospital 
(Mehler et al., 2010).  
 
2.2.5 Treatment  
 
Weight gain is crucial in the treatment of patients with AN. Weight gain trough regular meals 
sufficient in energy cause positive changes to the brain and hormonal system that make the 
patient receptive to other treatments (Mehler et al., 2010; Ornstein et al., 2003). Most of the 
medical complications will also be reversed when weight are recovered (Ornstein et al., 2003). 
However, osteoporosis may be persistent after recovery and reduced height growth (due to AN in 
adolescents) may not be fully catched-up. On the other hand, weight restoration and food intake 
is challenging in the recovery phase in patients with AN (Mehler et al., 2010).  
 
A relapsing or protracted course of the disease are common in adults and older adolescents 
(Zipfel et al., 2015), and the fully recovery rate of AN is as low as 33 %, but higher in 
adolescents than adults (Meczekalski et al., 2013). In adult patients, the average course of 
treatment before remission of the disease is 5 to 6 years (Zipfel et al., 2015). The definitions for 
complete recovery from this disease vary (in the literature), and a healthy weight within the 
normal ranges does not necessarily correspond to healthy attitudes concerning food, body, 




within normal limits and the concern for food, appearance and meals do not affect the social 
functioning, work or family life (Skårderud, 2000).  
 
Several psychological and pharmacological treatments are used in AN patients (family based 
treatment, cognitive behaviour therapy and others (Zipfel et al., 2015)), but will not be described 
further in this thesis. The physiological treatment with refeeding of these patients is described 
below.  
 
2.2.6 Refeeding of AN patients – guidelines and recommendations 
 
The guidelines in how to identify AN patients are presented in chapter 2.1.5. The following 
chapter will look at the different recommendations for how to refeed AN patients in an inpatient 
setting. In the guidelines presented in table 8 and 9, the refeeding range vary between 5-40 
kcal/kg/day, which means that an initial feeding range of a 30 kg patient diagnosed with AN, 
vary between 150-1200 kcal/day. The European and Australian guidelines are more restrictive 
and conservative than the American guidelines, but all guidelines are based on clinical practice, 
and not scientific evidence (O'Connor & Nicholls, 2013). The guidelines may differ somehow 
regarding if the guideline are made for all patient at risk of RFS (table 8), or is a guideline in how 
to reefed AN patients (table 9).  
 
Table 8 Recommended refeeding guidelines for malnourished patients at risk of RFS  
Guideline/ 
recommendation  
Age Kcal/kg Kcal/day Energy increase Supplementation 
NICE 1 Adult 5-20  * Slowly increase 
over 4-7 days.  
See table 10 
Europe (Stanga et 
al., 2008) 
Adult 10-15 * Up to 30 kcal/kg 
by day 10 
See table 10 
IrSPEN2 Adult 5-10 * * 50 mmol phosphate in a 
500 ml solution 
*not specified  
(National Institute for Health and Clinical Excellence, 2006; IrSPEN, 2015; O'Connor & Nicholls, 2013; Stanga et 
al., 2008) 
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Table 9 Recommended refeeding guidelines for malnourished patients with AN 
Guideline/ 
recommendation  
Age Kcal/kg Kcal/day Energy increase Supplementation 
NICE * * * 3500-7000 kcal 
extra/week 
Multivitamin/mineral 





Phosphate 500 mg 
twice daily and 
thiamine 100 mg 




Adult 30-40 1000-1600 
(1200) 
Increase with 100-
200 kcal/day. Up to 
70-100 kcal/kg 
* 





phosphorus rich foods 
JuniorMARSIPAN6 
 




phosphorus rich foods 
America (Sylvester 
& Forman, 2008)  




(Beumont et al., 2004; National Institute for Health and Care Excellence, 2004; O'Connor & Nicholls, 2013; Royal 
College of Psychiatrists, 2012, 2014; Sylvester & Forman, 2008) 
 
The American guidelines point out that some patients should start feeding at lower levels than 30-
40 kcal/kg because of the risk of RFS, but do not specify what that amount should be (Ozier & 
Henry, 2011). A variety of recommendations in the literature made to reduce the risk of RFS 
during refeeding ranges between 25-75 % of estimated energy needs (Fuentebella & Kerner, 
2009).  
 
“Kosthåndboken” (Helsedirektoratet, 2015), recommend starting refeeding of patients at risk of 
RFS (not exclusively AN patients) at 15 kcal/kg/day and closely monitor electrolytes like 
potassium, magnesium and phosphate. They recommend thiamine supplementation 
                                                                                                                                                              
2
 Irish Society for Clinical Nutrition and Metabolism 
3
 The Royal Australian and New Zealand College of Psychiatrists 
4
 American Psychiatric Association 
5
 Management of Really Sick Patients with Anorexia Nervosa, working group from the Royal Colleges of 
Psychiatrists, Physicians and Pathologists 
6




prophylactically before intravenous treatment with glucose starts. NICE-guidelines recommend 
correcting all electrolyte deficiencies before refeeding starts (Fuentebella & Kerner, 2009). 
 
Only two guidelines found are made specifically for adolescents, but these guidelines do not 
differ noteworthy from the others, except from a bit higher recommendation in the upper range of 
refeeding by Sylvester and Forman (2008) compared to the other guidelines. 
 
The table 10 below is taken from Stanga Z (2011), and is a summary of the guidelines from 
ESPEN7, which also cover the guidelines from NICE. These guidelines are made regarding all 
patients at risk of RFS, and not AN patients only. 
 
Table 10 Recommendations of refeeding, supplementing and monitoring patients at risk of RFS 
General recommendations  
Raise awareness within all health care personnel 
 Be aware of patients at risk 
 Provide adequate assessment, interdisciplinary care plans, and follow up 
 Appreciate that risks apply whether patients are fed by the oral, enteral or parenteral route 
 Carefully restore circulatory volume: monitor pulse rate and fluid balance 
 Energy intake should be instituted carefully and gradually increased over 4–10 days 
 Empirical supplementation of the electrolytes and vitamins can be started before feeding is 
initiated 
  
Days 1–3  
1. Energy (by all routes): start at 42 kJ/kg/day (10 kcal/kg/day) and slow increase to 63 kJ/kg/day 
(15 kcal/kg/day); 50–60% carbohydrates, 30–40% fat, and 15–20% protein. 
2. Electrolytes: measure serum concentrations basally, 4–6 h later, and daily during feeding (see 
below). Supplement prophylactically (unless pre-feeding plasma levels are high), in most cases by 
the intravenous route initially. Amounts depend on patient size and plasma concentrations, but usual 
daily requirements are: 
 Phosphate 0.5–0.8 mmol/kg/day 
 Potassium 1–3 mmol/kg/day 
 Magnesium 0.3–0.4 mmol/kg/day. Levels should be monitored frequently and supplements 
increased if necessary. 
3. Fluid: restrict to sufficient to maintain renal function, to replace deficits or losses, and avoid 
weight gain, that is achieve zero balance. Patients usually need 20–30 ml/kg/day. 
4. Salt: restrict sodium to <1 mmol/kg/day. If oedema develops, restrict further.  
5. Minerals and trace elements: 100% DRI. Iron should not be supplemented in the first week. 
6. Vitamins 200% DRI. Give 200–300 mg thiamine i.v. at least 30 min before feeding, and 200–
                                                 




300 mg daily i.v. or orally till day 3. 
7. Monitor daily 
 Body weight (fluid balance). 
 Clinical examination: oedema, blood pressure, pulse rate, cardiovascular and respiratory systems. 
 Biochemistry: phosphate, magnesium, potassium, sodium, calcium, glucose, urea, creatinine, 
(thiamine). 
 Preferably ECG-monitoring in severe cases. 
  
Days 4–6  
1. Energy (by all routes): 63–84 kJ/kg/day (15–20 kcal/kg/day); 50–60% carbohydrates, 30–40% 
fat, and 15–20% protein. 
2. Electrolytes: continue supplementation as above, giving more or less according to plasma 
concentrations. If the refeeding syndrome is already established, aim to restore normal levels. If 
 PO4 2- <0.6 mmol/l—give 30–50 mmol phosphate (eg. Phosphates Polyfusor) i.v. over 12 h. 
 Mg2+ <0.5 mmol/l—give 24 mmol MgSO4 i.v. over 12 h. 
 K+ <3.5 mmol/l—give >20–40 mmol KCl i.v. over 4 h. Remeasure and repeat if necessary. 
3. Minerals and vitamins: as for days 1–3. 
4. Fluid: depending on hydration, weight change and losses. Patients usually need 25–30 ml/kg/day. 
5. Monitor daily: as for days 1–3. 
  
Days 7–10  
1. Energy (by all routes): 84–132 kJ/kg/day (20–30 kcal/kg/day); 50–60% carbohydrates, 30–40% 
fat, and 15–20% protein. 
2. Electrolytes, minerals and vitamins: as above. Iron should be supplemented from day 7 onwards 
3. Fluid: to maintain zero balance. Approximately 30 ml/kg/day 
4. Monitor 
 Body weight and biochemistry: twice weekly 
 Clinical examination: daily 




















To answer the three research questions, three different data collections have been required. 
 
3.1  Procedure collection 
 
The regional departments with hospitalized patients with EDs in Norway are located in Oslo, 
Bergen, Stjørdal, Levanger, Bodø and Tromsø. The names of the departments (in Norwegian) are 
listed below: 
 
- Oslo:    “Regional seksjon spiseforstyrrelser” (RASP) 
- Bergen:  “Seksjon for spiseforstyrringar” 
- Levanger/Stjørdal:  “Regionalt kompetansesenter for spiseforstyrrelser” (RKSF) 
- Bodø:   “Regionalt senter for spiseforstyrrelser” (RESSP) 
- Tromsø:   “Regionalt senter for spiseforstyrrelser” (RSS) 
 
The procedures in the six regional departments of EDs in Norway were collected by contacting 
the head physicians in each regional department by e-mail, and the procedures was sent back by 
mail to the master student. If lack of information of their procedures was given, up to four 
















Table 11 The regional departments of EDs in Norway and two additional units. Number physicians and RDs 
working there and number of available beds for inpatient treatment per 01.01.16. 
Regional department/ 
ED unit 
Age group Number of 
beds 
Number of physicians/ 
number of RDs  
Other information 
RASP (Oslo) Intensive, 
all age 
groups 
8 11/3 Some rooms also available 
for families 









> 16 5 1/0 Planning 3 new beds next 
winter (2017) (total of 8 
beds) 
RKSF (Stjørdal) > 25 8 1/0 Patients with > 10y history 
of ED prioritized 
RKSF (Levanger) > 16 10 2/0  
RESSP (Bodø) > 18 12 2/1  4 beds reserved acute 
patients 




 55-56  17/4   
Modum bad (Modum) > 18 20 2/1  
Capio (Fredrikstad) 13-18 13 1/0 12 beds reserved 




Total all  88-89 20/5  
 
In these divisions, the number of physicians varied between 1-11 and number of RDs varied from 
0-3. Some of the units mentioned in table 11 use RDs from the local hospital in special cases 
when needed, but only 3 out of 8 units investigated have a RD. Numbers of other health 
personnel was not counted.  The number of physicians, RDs and available beds are collected by 




3.2  Questionnaire 
 
A questionnaire was developed and sent to physicians and RDs at the different ED units in 
Norway. Unlike the procedure collection, the questionnaire was also sent out to two other 
divisions that have inpatient treatment of EDs; Modum Bad (Modum) and Capio (Fredrikstad). 
This was to get a higher number of informants and to increase the strength of the survey. 
 
The master student made the questionnaire, with support from the supervisor and RDs at RASP. 
The questionnaire was made during the autumn, and during the process, the RDs and supervisor 
at RASP filled out the questionnaire as a pilot study. The questionnaire is located in Appendix 1. 
 
To identify all physicians and RDs working at the ED units, the student collected e-mail 
addresses to the leaders of each unit by calling them or contacting the supervisor at RASP that 
could assist with some of the addresses. In the mail sent to the leaders of each unit, the purpose of 
the questionnaire was described, and the e-mail addresses for all physicians and RDs working at 
their unit were requested. The e-mail addresses were sent back to the student by the leaders of 
each unit, or by the physicians or RDs working there themselves. As soon as the e-mail addresses 
were received, the questionnaire was sent back to the participants. This envoy starting at 16th of 
December until 18th of January. A reminder e-mail was sent up to four times if the participants of 
the survey did not answer. No questionnaires were received after first of March.    
 
Figure 4 Responders and no responders to the questionnaire 
 
A total of 25 physicians and RDs received the questionnaire; of which 20 physicians and 5 RDs. 




The student plotted in the variable sets and data sets from the questionnaires and did a descriptive 
analyse of the results using Statistical package for the social sciences (SPSS) analysis program 
(IBM SPSS Statistics Version 21, Release 21.0.0.2, 32-bit edition). Microsoft Excel 2010 was 
used to make the graphs and figures in this thesis.  
 
3.3  The basic reference menu 
 
The basic reference menu (“Grunnmeny”) at RASP is made in order to meet energy needs to 
maintain a stable weight when the weight have normalized in AN patients. The calculated energy 
content in “Grunnmeny” is 2650 kcal, which is higher than the recommendations from “The 
Norwegian Directorate of Health” (Helsedirektoratet, 2015) of 2300 kcal for women aged 18-30 
with moderate activity levels. Some patients maintain weight with lower energy intake. The basic 
menu for boys and men have a higher energy content. 
 
At RASP, most patients follow “Grunnmeny” or “Halv grunnmeny”, often after an escalation 
period over a few days/weeks. However, all patients get individual food lists, and the amount of 
energy they are prescribed, depends upon the patients’ energy intake at admission. Most patients 
also need a higher energy intake during the weight restoration period, but those menus are 
individual and are not analysed here.  It is worth noticing that “Halv grunnmeny” is not the true 
half of  the “Grunnmeny” meal content, but it reflects almost the true half energy content (about 
1400 kcal)  and is set up to specifically cover the recommendations of micronutrients (first and 
foremost phosphorus) and protein. Individual customization is made by RDs in individual food 
lists based upon the food choices or possibilities given in “Grunnmeny”. The meals are normally 
served to the patients the first two weeks by “milieu therapists” or parents. The patients have to 
serve themselves to each meal later on during the treatment period. For breakfast (cereals and 
porridge) and dinner, a demo plate is placed next to the dinner table so they know how much to 
serve themselves with. 
 
RASP has a four week rollover dinner menu made and calculated by the RDs at RASP. The 
dinner is the same for all patients in the weekdays and Sundays, but on Saturdays, the patients 
can choose between rice pudding and beta soup. The dinner menu has been set up to provide 




and food choices before discharge. The RDs have the responsibility of making the recipes and 
portion indications to all dinners, as well as all other meals (breakfast, lunch, evening meals and 
snack meals) during the day, to secure adequate energy and nutrients for the patients to reduce 
their underweight.  
 
To get an accurate estimate of the content of the dinner portions, portion sizes from the 
demonstration plates that were used in the meal session for the patients through four weeks were 
collected, weighted and photographed by the master student. The aim was to check if the 
recommended content of the dinner portions by the RDs matched the actual portion sizes served, 
or if there were major deviations in nutrient content. Other meals (breakfast, lunch, evening meal 
and snacks) were not weighed. In total, 25 dinner portions were weighed and photographed, of 
them seven at the master student’s home. On Saturdays, the patients can choose between two 
options, and these options are the same every week, and were therefore only weighed once. 
 
Ordinary kitchen scales located at the kitchen at RASP was used to weigh the dinner portions 
(OBH Nordic, “Balance”, maximum capacity 5 kg, accuracy 1 gram). Most of the weighing was 
done at RASP the same day, or the day after the dinner was served. If the weighing was done the 
day after, the dinner plate was stored in the fridge, covered by cling film. If the demonstration 
plate was thrown away before the student had measured the weight, the student made the dinner 
at home by following the recipes and measures used at RASP, and followed the same procedure 
of taking picture of and weighing the food. A different scale was used at home (ELDOM, 
maximum capacity 5000 g, accuracy 1 gram). 
 
In addition to the weighing of the dinner plates, a variety of meal options from the “Grunnmeny” 
(Appendix 4) and “Halv grunnmeny” (Appendix 5) was plotted into “Kostholdsplanleggeren”. 
The contents of these lists was analysed with the intention of comparing them with the 
recommended energy and nutrient prescription for patients at risk of RFS. The most probable 
eaten food and drinks, in addition to the dinner portions, in order to quantify average 
micronutrients and energy during a 7-day period were analysed. Different possible weekly food 
lists were analysed, 4 based on “Grunnmeny” and 4 based on “Halv grunnmeny”.  
The software system “Kostholdsplanleggeren” (Version KP-2014) was used to analyse the 




Directorate of Health and the Norwegian Food Safety Authority (Matportalen, 2016), that is 




The results are presented in three different chapters. These are divided into the results from the 
procedure collection, the results from the questionnaire and the results from the review of the 
basic reference menu (“Grunnmeny” and “Halv grunnmeny”) at RASP.  An overview of the 
regional departments and the two other ED units included in the results are presented in table 11.  
 
4.1 Procedure collection 
 
From the six regional departments of EDs investigated, three of them (50 %) had developed their 
own procedures regarding RFS. RESSP (Bodø) and RKSF (Levanger) had a procedure that 
includes both how to identify patients at risk, and a procedure in how to treat and monitor these 
patients. RASP had a procedure, but only for which blood tests and medical examination that 
these patients should have, not a procedure in how to identify or refeed these patients.   
 
To identify patients at risk of RFS, there were some differences between RESSP and RKSF. 
RESSP follow the NICE-guidelines in how to identify patients at risk (table 3). RKSF had made 
their own procedure, and defined patients at risk as: 
 
- Patients with BMI < 11  
- Patients with a BMI 9.5-11 and a nutritional intake of 10-15 kcal/kg the last 10 days are 
characterized as in high risk 
- Patients with a BMI from 7.0-9.5 and nutritional intake of < 10 kcal/kg the last 10 days 
are characterized as in extremely high risk. 
 
Blood test and supplements that all hospitalized patients at a regional department of EDs receive 
are located in Appendix 2. The following tables describe additional supplementations, medical 




and monitor these patients. Only the Norwegian departments that have such procedures are 
included in the tables. The routines at the other departments that do not have specific procedures 
regarding RFS are described afterwards. 
 
Table 12 Procedures for medical and biochemical evaluation, nutritional- and fluid recommendations for patients at 
risk of RFS 






weight 1-2 times a 
week. 
* ECG8, pulse, blood 
pressure, dyspnoea, oedema, 
relative tachycardia  




Na+9, K+10, Clˉ11, 
phosphate, calcium 
total, calcium 
ionized, Mg²+12 for 




electrolytes daily the 
first week, weekly 
when stable 
Na+, K+, Mg²+, phosphate 
until the patient is following 
A-menu13. Later 3x/week 
for 21 days or when the 
patient have stable body 
weight 
Nutrition ”Halv grunnmeny” 
(about 1350/1400 
kcal), or less than 
”Halv grunnmeny” 
High risk: Half or less 
than half of dietary 
lists 
 
Extremely high risk: 





10 kcal/kg/day, 8-12 
meals/day (including 
one at 2am) 
20-30 kcal/kg/day  
Gradually increase for 4-7 
(10) days.  
Extremely high risk: 
Even lower energy is 
recommended 
 
No use of brown goat 
cheese, jam or dessert 
before the patient is stable 
and following A-menu. 












Dietary list at RESSP (approximately 2200kcal) 
14
 Nutritional drinks 
15




Fluid * 20-30 ml/day, 25-30 
ml/day by day 4.  
 




1-1.5 liters/day.  
 
No sugar containing drinks 
(juice, soda, and 
sugar/honey in tea/coffee) 
before the patient is stable 
and following A-menu. 
Biola and milk are ok. 
* not specified in procedures 
 
The procedures at RASP do not specify the fluid recommendations of a patient at risk of RFS, but 
the RDs use fluid restrictions and assess fluid intake depending on what the patients are able to 
drink and due to probable risk of RFS but also risk of oedema formation especially at the first 1-2 
weeks of refeeding. Normally, the patients are given 1000-1400 ml in the refeeding phase, and in 
“Grunnmeny”, they recommend 1900-2100 ml. If patients at RASP (Oslo), RKSF (Levanger) and 
RESSP (Bodø) are identified by the procedures as at risk of developing RFS, they are given 
supplements prophylactically (table 13) before, refeeding is started to reduce the risk of 
developing deficiencies and complications during the initial refeeding.  
 
Table 13 Prophylactically supplementation of patients at risk of RFS  
 Oslo Levanger Bodø 
Thiamine 50 mg x 1 for 5 days (IM16) Individual 
evaluation 
100 mg x 1 for 3 days or 
50 mg x 1 for 5 days (IM). 
Always first injection 
before refeeding  
Phosphate Preventive: 
Monokaliumphosphate 15mmol 
x 2 or phosphate-Sandoz 500 
mg x 2  
If identified hypophosphatemia:  




Calcium 500 mg with vitamin D* Individual 
evaluation 
Individual evaluation 
Potassium ** Individual 
evaluation 
Individual evaluation 




*all patients, not exclusively for at risk patients 
**no supplementation according to procedure 






The procedures collected are located in Appendix 3 (chapter 7.3.1-7.3.3). 
 
All six head physicians that were contacted regarding the procedures pointed out that they always 
do a detailed medical and biochemical examination of each patient. This included tests like 
electrocardiography (ECG), blood pressure, weight and height, pulse, respiration, coordination, 
skin (dryness/lanugo hair), urine etcetera. However, the impression during the procedure 
collection was also that RFS is something the head physicians are aware of, but a condition they 
rarely or never experience. 
 
Those departments that did not have a procedure in how to refeed and monitor patients at risk of 
RFS still had procedures or routines in how to reefed AN patients in general, and during the 
procedure collection some comments were provided as to how these departments deal with AN 
patients at risk of RFS. 
 
“Seksjon for spiseforstyrringar (Bergen) give at risk patients half „Basiskost“ which have 
about 1000 kcal (“Basiskost” have approximately 2000 kcal). At risk patients are all that have 
eating little or nothing the last two weeks. If a patient is identified as at high risk of developing 
RFS, they give nutritional drinks in several small meals during the day. They start with 15-30 
kcal/kg/day, and increase up to 30 kcal/kg/day. If the patients tolerate this increase of energy, 
additional 200 kcal (in terms of food or nutritional drinks) are added to the energy requirements 
every other day, until an increase in body weight of 1-1.5 kg/week are reached.  
 
They give supplements of multivitamin, omega 3 and calcium 500 mg/day. Electrolytes are 
monitored, and if s-phosphate drops below 0.85 mmol/L, the nutritional support is decreased or 
stopped until s-phosphate are stable. If phosphate levels are > 0.7 mmol/L it is sufficient to give 
the patients food choices high in phosphorus or phosphate mixture. If phosphate levels drop to < 
0.5 mmol/L, the patient should be transferred to the medical department to get phosphate 
intravenously.    
 
RKSF (Stjørdal) have dietary lists for all patients, which consist of about 2000 kcal. At risk 
patients could start with half or reduced dietary list, and gradually increase up to full dietary list. 




patient done twice a week. If the patient has a BMI < 14, nutritional drinks are recommended as a 
supplementation to the dietary list. 
 
RSS (Tromsø) monitor phosphate and hydration in at risk patients. What is defined as at risk 
patients are not mentioned. If a patient is designated as at risk of developing RFS, refeeding is 
started at 1500 kcal, and increased with 250-300 kcal every third day up to a dietary list at 2400 
kcal (or even more energy in terms of food or nutritional drinks if necessary). If patients are 
designated as in high risk, an additional dietary lists starting at 1200 kcal may be used. They 





Answers were received from physicians and RDs that worked at four out of eight of the ED units 
from which the questionnaire were sent out to. In total 13 responded, of which five RDs (100 %) 
and eight physicians (40 %) responded. There was a wide range (0.5 to 34 years) between the 
responders who had worked with this patient group for a long time and those who had just 
started. The mean working years were 7.8 years and the median was 2.5 years. The mean 
working years for RDs was 4.6 years and physicians 9.8 years.  
 
The answers do not concern any specific patients, but are opinions and perceptions given from 
the physicians and RDs working with this patient group (AN). Their subjective opinion and 
experiences are collected and analysed to give an overview of the knowledge, opinions and 
awareness of RFS considering AN patients hospitalized at an ED unit with inpatient treatment. 
This section do not only concern with physicians and RDs at the regional departments of EDs, 
but physicians and RDs at two additional units.  
 






4.2.1 Procedures to prevent refeeding syndrome 
 
Ten responders (77 %) answered that their department had specific procedures made by the unit 
to detect and treat patients at risk of RFS. Eleven (85 %) answered that their ED unit on the other 
hand had a procedure that would detect patients at risk of RFS anyway, even if the procedures 
were not made exclusively for AN patients at risk of RFS.  
 
4.2.2 Knowledge about refeeding syndrome 
 
Four out of thirteen (31 %) of the physicians and RDs thought they had satisfying knowledge 
about the RFS, and that they were able to start treatment without obtaining more knowledge. Out 
of these four, one was RD and three were physicians. However, the rest of the responders felt that 
they knew enough about RFS, but they that would confer with other health personnel before they 
would start treatment to ensure that the treatment and monitoring was proceeding right.  
 
Regarding education about RFS, all RDs answered that they had learned about the RFS during 
their education. The physicians had variable answers, with only one reporting to have learned 
about RFS during education. The physician who reported to have learned about the RFS during 
education was the youngest of the physicians. 
 






     4.2.3 Definition of refeeding syndrome 
 
Five responders (38 %) reported that they were unsure of the diagnostic criteria of RFS, but still 
listed what they thought should be present to diagnose a patient with RFS. Some of the signs and 
symptoms were reported as should be present more than others, but all the alternatives used in the 
questionnaire were marked. There was no clear differences between the answers form physicians 
and RDs. Overall, the answers received were divided, indicating uncertainty or disagreements.  
 
The five most common factors reported that should be present to diagnose a patient with RFS 
were:   
- Phosphate < 0.5 mmol/L 
- Cardiac arrhythmias 
- Peripheral oedemas 
- Pulmonary oedemas 
- Heart failure 
 






To this question, the responders could also comment their answers. Corrections of declines in 
hypophosphatemia, hypokalaemia, hypomagnesaemia and hyperglycaemia were pointed out as 
important. One reported that Ca levels < 1.9 mmol/L is a sign of RFS or beginning RFS. 
Tachycardia, circulatory failure and cerebral symptoms were also listed as symptom of RFS. 
Some of the responders pointed out that even if they listed some signs and symptoms that should 
be present to define something as a full-blown RFS, they were not sure if these symptoms 
themselves were enough to diagnose a patient. These symptoms could be observed, but the 
patients may still not have RFS.  
 
4.2.4 Patients at risk of refeeding syndrome 
 
Of the responders, 12 (92 %) answered that they have been in contact with patients at risk of 
developing RFS. Only one responder (8 %) answered no to this question.   
 
4.2.5 Patients with abnormal values or symptoms 
 
Nine responders (69 %) had seen patients with declines in electrolytes or symptoms indicating 
that the patients were developing RFS. The number of patients observed with such abnormalities 
during the last year varied between 0 to 10, with a median of three patients.  
 
The electrolytes observed were (number of responders answered in parenthesis): 
- hypophosphatemia (6) 
- hypokalaemia (5) 
- hyponatremia (3) 
- hypocalcaemia (2)  
or signs; 
- oedemas (3) 
- hypoglycaemia (2) 
- muscle weakness (1) 
- dyspnoea (1) 





All patients reported by the responders were refed with food only, or in combination of EN or 
nutritional drinks. No patients experienced these abnormalities received PN.  
 
4.2.6 Patients with refeeding syndrome  
 
Only one (8 %) of the responders to the questionnaire had seen a patient with full-blown RFS. 
This patient was refed with food and nutritional drinks, with no use of EN or PN support. Why 
this patient developed the syndrome, what criteria that were fulfilled to diagnose the patient with 
RFS or other relevant factors is not described.  
 
4.2.7 Initial weight loss 
 
One of the responders answered that patients that follow prescribed food lists and recommended 
energy intake initially lose weight often, 7 answered that this happens occasionally, 4 answered 





















The following three sections (4.2.8-4.2.10) are linked to the patient case in the questionnaire:  
 
«Kvinne 19 år, spiseforstyrrelser siden 14- års alder. Restriktiv anoreksi med oppkast, 
aktivitetstrang og misbruk av laksativer. Løs avføring/diare. Veier 28 kg og har en BMI på 12,6 
kg/m2 ved innkomst. Får i seg ca 1000 kcal/dag via sonde og mat.»  
 
4.2.8 Blood samples 
 
The responders were asked what they thought was the most important blood tests to take 
regarding detecting and monitoring the risk of RFS in this patient. One answer was taken out of 
the analysis due to misunderstanding of the question.  
 
Five blood tests stood out (percent of responders answering this in parenthesis), and that were 
sodium (83.3 %), phosphate (100 %), glucose (66.7 %), potassium (100 %) and magnesium (75 
%).  
4.2.9 Initial feeding of one patient at risk of RFS – an example 
 
The amount of energy or kilocalories the responders would recommend initially in the case given, 
varied from 1000-1400 kcal/day, with a median of 1100 kcal. Six (46 %) out of 13 would have 
started with 1000 kcal. All of them suggested food or a combination of food, nutritional drinks 
and EN. The preferred feeding in RFS methods are presented in the figure below. No one would 
use PN as a feeding method if not necessary. 
 
Figure 7 Number of responders answering that they will give the patient from the case food only, EN only or a 








In the question about energy distribution between proteins, carbohydrates and fats, three of the 
RDs pointed out that carbohydrates, and especially added sugar, should be limited in the first 
weeks of refeeding. Other than that, responders pointed out that the national guidelines should be 
followed. Some also pointed out that the protein content should be in the higher range of the 
recommendations to get enough protein/nitrogen compared with lean body mass and muscular 
growth.  
 
4.2.10 Supplements and monitoring 
 
The responders were asked about which supplements they would recommend and if they wanted 
to give the supplement prophylactically or only when levels dropped or was low.  
 
Table 14 Number of responders answering that they will give supplements to patients at risk of RFS prophylactically 
 Intramuscular Per os 
Thiamine 10 (76.9 %)  
Phosphate  8 (61.5 %) 
Magnesium 1 (7.7 %) 7 (53.8 %) 
Omega 3  9 (69.2 %) 
Multivitamin  8 (61.5 %) 
Vitamin D  5 (38.5 %) 
Calcium  6 (46.2 %) 
 
The last question in the questionnaire was about monitoring of the patient. Ten out of 13 would 
have monitored the patient once daily during the first two weeks of refeeding. One would have 
done the monitoring every other day, and 1 twice a week. One responder did not answer this 
question. On the question of how long the physicians and RDs would have monitored the patient 
beyond these two weeks, 6 responded that they would monitor until the patients electrolytes are 
stable, 2 responded they would monitor for another two weeks, and 5 responded that they would 
monitor the patient even longer than additional two weeks. How often the monitoring should be 




4.3  Basic reference menu 
 
Only the basic reference menu at RASP is analysed, and the menus used at the other ED units are 
not investigated in this thesis.  
 
Table 15 An example of a daily food list for a patient hospitalized at RASP  
Breakfast 1 portion of porridge (4 dl) 
1 glass (200 ml) Biola  
1 apple 
2 capsules omega 3 
Lunch 3 slices whole wheat bread 
1 slice of crisp bread 
2 pk Soft flora (margarine) 
1 egg (boiled) 
1 portion of “Prim” 
1 portion cream cheese 
2 slices of cucumber 
2 slices of tomato 
1 glass (200 ml) of milk (1.2 % fat) 
1 apple 
Dinner 1 slice of pie with ham, egg and cheese 
Salad: raisins, lettuce, apple, carrot 
1 glass (200 ml) juice 
1 yoghurt (dessert) 
Evening meal Cereals (1.75 dl) and milk (2.5 dl) 
1 glass (200 ml) of milk (1.2 % fat) 
1 orange 
 
The table above is only an example of how one day with “Grunnmeny” may look like, and the 
patients have different options for each meal (Appendix 3). The results of the master students 
weighing of the dinner portions in “Grunnmeny” are presented in table 16. The amount of 




428 kcal. The mean energy content was 482 kcal (SD 100). The dinner portion with the lowest 
calorie content was the vegetarian pizza, with only 234 kcal. In the recipe of this dish, there is no 
guideline in what the weight and thickness of the slice should be but only a reference of size 12 x 
15 centimeters.  
 
Table 16 Kilocalories in each weighed dinner portion during the four week rollover menu (“Grunnmeny”). 
Beverages and dessert not included.  
 Week 1 Week 2 Week 3 Week 4 Average Minimum - 
maximum 
Monday 662 631 417 431 535 417-662 
Tuesday 547 570 488 494 525 488-570 
Wednesday 386 595 421 575 494 386-595 
Thursday 433 477 431 234 394 234-477 
Friday 442 514 584 604 536 442-604 
Saturday 410 339 410 339 375 339-410 
Sunday 567 458 576 456 514 456-576 
Total average 492 512 475 448 482 234-662 
 
 
Table 17 Kilocalories in each dinner portion in the “Halv grunnmeny” during the four-week rollover menu. 
Beverages and dessert not included.  
 Week 1 Week 2 Week 3 Week 4 Average Minimum - 
maximum 
Monday 331 315 208 215 267 208-331 
Tuesday 273 285 244 247 262 244-285 
Wednesday 193 298 211 288 248 193-298 
Thursday 217 239 216 117 197 117-239 
Friday 221 257 292 302 268 221-302 
Saturday 205 170 205 170 188 170-205 
Sunday 284 229 288 228 257 228-288 




From the weighing of dinner portions from “Grunnmeny”, the dinner portions of “Halv 
grunnmeny” was calculated concerning energy and nutrient content. These portions were not 
weighed, but only calculated from “Kostholdsplanleggeren”. The amount of kilocalories 
calculated in these dinner portions varied from 117-331 kcal, with a mean energy content of 241 
kcal (SD 50).  
 
In the following, “Grunnmeny” and “Halv grunnmeny” is separated into two different chapters. 
First, the results from the analysis of “Grunnmeny” are presented. Thereafter, the results from the 
analysis of “Halv grunnmeny” are presented.  
 
 
4.3.1 Basic reference menu – “Grunnmeny” 
 
“Grunnmeny” is the comprehensive food system that is the main framework for the nutritional 
treatment and rehabilitation of the patients with AN and EDs at RASP. This system has been 
worked out to secure the patients enough energy and nutrients but also to expose the patients to 
different normal foods and tastes that is a challenge to these patients. The “Grunnmeny” system 
makes predictability for the patients of what to eat and that are considered important due to the 
high anxiety these patients have related to food.  All results and tables below include not only the 
dinner portions, but analysis of all food prescribed in four meals during one day. 
 
Table 18 The average daily energy prescribed, including all meals, snacks and beverages 




2618 2718 2566 2612 2629 
Minimum - 
maximum 
2463-2818 2481-2929 2471-2700 2237-2841 2237-2929 
 
Week 4 includes the dinner that was very low in calories (table 15), and thus the energy content 
of the whole day is affected, resulting in a prescribed energy content of 2237 kcal, which is more 




Table 19 Energy distribution (E %) in “Grunnmeny” at RASP 
 Week 1 Week 2 Week 3 Week 4 Average Recommended 
Carbohydrates, E % 













Dietary fiber, g 44 46 46 45 45 25-35 
Fat, E % 28 32 26 29 29 25-40 
Protein, E % (g) 19 (125) 18 (125) 19 (119) 18 (119) 19 (122) 10-20 
 
 
Table 20 Contents of vitamins and electrolytes in “Grunnmeny” 





2.73 2.51 2.73 2.73 2.68 2.51-
2.73 
1.1 





1933 1823 1887 1908 1887.8 1823-
1933 
800 
Iron, mg 14.5 14.7 14.7 13.1 14.25 13.1-
14.7 
15 
























Omega 3 capsules or “tran” are implemented in the basic reference menu at RASP, and included 
in the analysis. Without this supplementation, levels of vitamin D would have decreased with 
almost 4 fifths, highlights the importance of this supplementation. As an example, the vitamin D 
content of one day in week 1 would be as low as 4.7 µg, with an average of 7.5 µg during the 
whole week. The recommendations of omega 3 will not be met without this supplements either, 
and contribute to less than the recommended 1 E % if not supplemented.  
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Multivitamin and calcium supplements are not included in the results. These supplements should 
be added to the “Grunnmeny” and “Halv grunnmeny”. It varies if patients receive these 
supplements or not, depending on previously food intake, which supplements they already 
receive and the patients’ willingness to take these supplements.  
 
4.3.2 Reduced basic reference menu – “Halv grunnmeny” 
 
Results from the analysis of “Halv grunnmeny” are presented in the following chapter. All results 
and tables below include not only the dinner portions, but also analysis of all food and beverages 
prescribed during a day or week. 
 
Table 21 The average daily energy prescribed, including all meals, snacks and beverages 




1352  1538  1343 1413 1411 
Minimum - 
maximum 
1236 - 1421 1455 - 1674 1247 - 1458 1212 – 1567 1212 - 1674 
 
The estimated amount of kilocalories given each day in “Halv Grunnmeny” varied from 1212-
1674 kcal, which was a difference of 462 kcal. This variation would again be higher or lower due 
to the patients’ specific choices and possibilities in the “Grunnmeny”.   
 
Table 22 Energy distribution in “Halv grunnmeny” at RASP 
 Week 1 Week 2 Week 3 Week 4 Average Recommended 
Carbohydrates, E % 













Dietary fiber (g) 18 19 18 18 18 25-35 
Fat, E % 32 37 31 32 33 25-40 





The energy distribution of macronutrients and sugar in “Halv grunnmeny” is similar to that in 
“Grunnmeny” (table 19). The contents of fiber (in grams) are lower due to less food and energy. 
As for the “Grunnmeny”, the micronutrients in “Halv grunnmeny” are calculated and presented 
in the table below. 
 
Table 23 Contents of vitamins and electrolytes in “Halv grunnmeny” 





1.39 1.54 1.26 1.38 1.39 1.26-
1.54 
1.1 





1387 1200 1420 1340 1336.75 1200-
1420 
800 
Iron, mg 6.4 7.8 6.1 6.3 6.65 6.1-7.8 15 
























The recommendations for most micronutrients are covered, with the exception of folate, iron and 
potassium in ”Halv grunnmeny” at RASP. Supplements of omega 3 are included in the analysis, 
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The discussion is presented in the same order as the results; discussion and differentiation 
between the procedures, discussion of the results from the questionnaire and discussion of the 
basic reference menus, “Grunnmeny” and “Halv grunnmeny”, at RASP. Strengths and 
weaknesses of the methods used, and strengths and weaknesses of the results, are discussed after 
each result. 
 
5.1  Procedures 
 
Results from the procedure collection found that there is a difference between if the regional 
departments of EDs have developed their own procedures to prevent RFS, if they do not have 
such procedures or if they use international guidelines. There is variety in treatment options 
within a certain guideline, implying that individual customization for each patient has to be made. 
That these discrepancies are found between the regional departments of EDs in Norway is not 
surprising, considering the inequalities of other (international) guidelines, both regarding RFS 
and treatment of patients with AN (O'Connor & Nicholls, 2013) (table 8 and 9).  
 
Considering the patient group that is hospitalised at the regional departments of EDs in Norway, 
there is a bit of a concern that not all of them have procedures to detect and treat patients at risk 
of RFS or that they follow common guidelines. In the literature, AN patients are referred to as a 
group of patients that may be in high risk of RFS (Kraft et al., 2005; H. Mehanna et al., 2009). 
Patients with other EDs may also be at risk, like BN (due to purging/vomiting), or patients with 
extreme weight fluctuations or extreme exercise (Mehler & Rylander, 2015), all possible patients 
at a regional department of EDs. Without procedures, the system is vulnerable if experienced 
health personnel quit their job. A procedure may be favourable for the safety of patients, because 
a procedure may secure that all patients are assessed and monitored. If a common procedure does 
not exist, some patients that may be at high risk are not detected.  
 
The criteria for which patients that should be identified as at risk of RFS differ between RESSP 
(Bodø) and RKSF (Levanger). The difference between BMI cut-offs of patients considered at risk 




Why there is such huge discrepancy between the recommendations should be a topic of further 
investigation. A possible explanation is that the health personnel working at RKSF (Levanger) 
have extensive experience and feel confident that RFS is not relevant in patients that are 
moderate malnourished. One other contributing factor could be that NICE-guidelines, which are 
used by RESSP (Bodø), are made to identify all patients at risk of RFS, and may consider 
patients with other comorbidities as in higher risk than AN patients. Guidelines that are made to 
identify patients at risk of RFS and guidelines how to reefed patients at risk is debatable in terms 
of the transferability to AN patients. The NICE-guidelines may also be too restrictive, or the 
procedure made by RKSF may be too radical.  
 
The regional departments of EDs treat different age groups, and this may contribute to the 
difference in awareness of RFS among the clinicians. The risk of RFS in AN patients may differ 
between adults and adolescents. Adults may be at higher risk because of longstanding 
malnutrition, while adolescents may have higher risk due to higher metabolic rates (Whitelaw, 
Gilbertson, Lam, & Sawyer, 2010). Compared to the results from procedure collection, a 
difference in how to identify patients at risk of RFS may be seen between RKSF (Levanger) and 
RESSP (Bodø) due to age of patients (table 11).  
 
Refeeding of patients with AN considering calculation of initial calorie recommendations is 
varying in the procedures collected. The procedures to avoid RFS in the regional departments 
have an initial feeding of 10-30 kcal/kg, dependent on severity and underweight of the patients. 
Most units operate with half food lists or food lists of about 1000-1500 kcal. Initial refeeding 
range is further discussed in chapter 5.2. 
 
Studies have found that there is no association between initial energy prescription and cases of 
hypophosphatemia (the hallmark of RFS), but rather an association between % of IBW and cases 
of hypophosphatemia (Le Grange, 2013). This correlation between % of IBW and cases of 
hypophosphatemia is also shown by Ornstein et al. (2003). In adolescents, studies have found that 
percent of IBW (< 70 %) is a better predictor of patients at risk than energy intake (O'Connor & 





Other studies have found that there is a direct link between the risk of RFS and degree of weight 
loss before admission (Mehler et al., 2010). The risk of developing RFS would also depend on 
the patient’s previous intake of micronutrients, purging and exercise (Stanga et al., 2008). How 
aggressively the refeeding is thought to be should also be assessed against how much the 
individual patient has eaten e.g. the last week(s), and give the gastrointestinal tract a possibility to 
cope with the food given and to reduce eventual abdominal pain (Mehler et al., 2010) 
 
Close monitoring and evaluation of each patient at risk of RFS are important (Ornstein et al., 
2003), and instead of giving supplements to all patients, it may be just as effective to treat 
hypophosphatemia if it occurs. RSS (Tromsø) pointed out that only one patient has had to be 
supplemented with phosphate during the last six years. RASP (Oslo) provides phosphate 
prophylactically in high-risk patients, while RKSF (Levanger) and RESSP (Bodø) evaluate the 
requirements for each patient according to their procedures. “Seksjon for spiseforstyrringar 
(Bergen)” supplements with phosphate mixture if necessary. 
 
It seem like during this investigation that RFS is something all regional departments of EDs have 
in mind, but something they do not experience to be a common part of their practice. This may be 
due to the procedures in the regional departments of EDs in Norway being satisfactory, the 
physicians and RDs may be trained to detect these patients or it may also be due to that the most 
severe cases of AN being hospitalized in medical wards, not in ED units. As it is today, each 
department has their own procedures regarding medical examination, refeeding and monitoring. 
Such inconsistence produces several limitations to consider whether the treatments in the 
different departments are comparable. 
There are few publications considering the importance of RDs in ED units, but a RD is important 
in the nutrition care of a patient with an ED (Mehler et al., 2010). A food history of resent and 
normal food intake is often more accurate to predict micronutrient deficiencies than laboratory 
test (Ozier & Henry, 2011). A RD calculate energy needs, monitor and make meal plans to 
achieve weight restoration (Mehler et al., 2010). In addition, “Elektrolyttveilederen” (2014) 
recommends that all patients in high risk of RFS should consult a RD. The RD closely follows 
blood tests during the refeeding state, and this would most likely detect any nutritional 
shortcomings. If the patient refuse to eat or need EN or PN of other reasons, an RD is important 




treatment goals as considered from the RDs is to help the patients relearn or experience by 
themselves what normal food should consist of and how much energy that is actually needed both 
to reduce underweight but also how much food actually is needed to keep a healthy weight. This 
nutritional rehabilitation is considered important to start early at inpatient units due to the 
importance of good habits to develop and to reduce the risk of relapse (Sachs et al., 2015). After 
discharge the patients usually have quite some experience in healthy recommended food habits 
and food choices that could be one of several pieces to avoid relapse due to bad food habits or 
lack of knowledge how to take care of the body (Sachs et al., 2015). 
 
Table 11 shows that the number of RDs working at an ED unit per 01.01.2016 is as low as 5. A 
further concern is that three of them are working at RASP (in addition to 1 at RESSP (Bodø) and 
1 at Modum Bad), which means that the other units do not have an RD at all. Even if not 
investigated in this thesis, the impression made by the master student is that RASP (Oslo) and 
RESSP (Bodø) also have an attention to the individual dietary lists and the contents of this, to a 
greater extent than the other departments. How this affect the total treatment offers, risk of 
relapse or patient experience needs to be investigated.    
 
5.1.1 Strengths and weaknesses of the procedure collection 
 
One of the greater weaknesses within this study is the difficulty of receiving proper or true 
information from the different regional departments of EDs, and to know whether this 
information is actually true for all clinicians. This may be due to lack of knowledge from the 
person that was contacted, or that they did not prioritize to answer the questions given. Some did 
just answer in a short mail, while others sent detailed information of their written procedures. 
Even with several remainder emails, it was difficult to get an affirmative or negating answer on 
the question if the information received was written procedures and followed by their clinical 
staff within their department or not, or if the information given just was routines (not written), or 
common practise. The information gathered from the departments that claimed that they do not 
have a procedure regarding RFS, may still have the information written down in other 
procedures. Overall, the information gathered was deficient, and it is tempting to believe that 




Physicians pointed out that RFS is a rare problem in their department, and the difficulties with 
getting information from the head physicians may have been due to that they do not see the 
importance of investigating the procedures. Even if international guidelines recommends that 
patients with AN should be monitored regarding RFS (National Institute for Health and Clinical 
Excellence, 2006), this view may not be shared among clinicians working at the regional 
departments of EDs in Norway.  However, that a department does not have procedure do not 
directly imply that they do not detect these patients and have routines to treat patients at risk of 
RFS. There is difficult to conclude if recommendations are followed based on the collected data 
in this thesis.  
 
A better method to collect the procedures could have been to visit each regional department and 
ask for the procedures in person through a personal interview with the head physician. In that 
way, confusion and misunderstanding regarding what was asked for could have been eliminated, 
and instead of having email correspondences lasting for months, the procedures would have been 
collected during a few hours. Otherwise, this option was not used due to economic reasons, 
because there was no budget for travelling, and it would maybe have been difficult to arrange an 
appointment in an otherwise hectic workday with the head physicians.  
 
 
5.2  Questionnaire 
 
What physicians and RDs define as full-blown RFS is comparable to the diagnostic criteria found 
in the literature (Hofer et al., 2014). That all RDs and only one of the physicians responding to 
the questionnaire remember to have learned about RFS during education was an interesting 
result. Considering only 3 out of 8 units of EDs included in the questionnaire have a RD, this 
could contribute to the differences of awareness of this syndrome between the different ED units.  
 
The high number of physicians and RDs (93 %) reporting to have been in contact with patients at 
risk of RFS is not surprising since this survey was done among physicians and RDs working at 
specialized ED units. The diagnostic criterion of AN is among others to have a BMI < 17.5 and 





The rarity of RFS was confirmed in this survey. Only one of the responders claims to have seen 
the syndrome, even though 38 % of the responders have worked in this field for 10 years or more. 
The incidence of a full-blown RFS is not investigated in this thesis and due to the rarity of the 
syndrome (expressed by answers in the questionnaire), and the number of incidences would have 
been extremely low or zero considering the time limits of a master thesis of a year.  
 
Decline in electrolyte levels and symptoms indicating that a patient is developing RFS are 
observed by nine of the responders to the questionnaire. That hypophosphatemia is the most 
common symptom reported, may be due to that the awareness of hypophosphatemia in patients at 
risk of RFS are highlighted in several articles (H. M. Mehanna, Moledina, & Travis, 2008; M. A. 
Crook, 2014 ). Symptoms as hypophosphatemia seems to be common accepted as a symptom of 
RFS, while others are debatable (H. M. Mehanna, Moledina, & Travis, 2008). It may be 
confusing for clinicians that several signs and symptoms have to be present to identify a patient 
experiencing RFS. A drop in phosphate or other electrolytes will be corrected by supplements, 
and other measures may contribute to the low incidence of severe symptoms. A diet with focus 
on phosphate rich foods, or supplementation of thiamine and multivitamins prophylactically may 
eliminate the incidence of full-blown RFS (Royal College of Psychiatrists, 2014).  
 
According to “Elektrolyttveilederen” (2014), the most important blood test and medical 
examination to detect RFS are phosphorus, potassium, magnesium and glucose, as well as ECG 
and weight. This is almost what was found in the answers from the questionnaire, with the 
exception of that most responders also mentioned sodium as important to assess. Weight and 
ECG was not an option in the questionnaire. 
 
Results from the questionnaire show that several of the physicians and RDs experience that 
patients lose weight initially when starting refeeding, even if they eat what they are prescribed. 
This indicates that the dietary lists and calculated energy needs may be underestimated, and may 
result in a worsening of the disease for the patient, and increase the risk of cardiac problems, 
increased length of hospitalization and increased mortality (Kohn et al., 2011). Other factors 
favourable a lower energy intake initially, due to the fear of food and weight gain in AN patients 
(Zipfel et al., 2015). A slowly increase in energy may contribute to more cooperative patients and 




High calorie diets given continuously with EN, together with food, may reduce length of stay 
with 17 days compared to bolus fed patients (Agostino et al., 2013). This is important both to the 
patient (and patient families) social life, economy of the hospital and statistical relevance. 
Continuous feeding with EN may reduce the insulin surges that normally are induced with bolus 
feeding (Agostino et al., 2013), and EN may be used to refeed patients at high risk of RFS. Even 
though this might be true, the practicality of continuous EN has to be questioned due to a 
common problem that the patient quite often would refuse this option.  
 
One of the questions in the questionnaire was about initial feeding range of a case presented. The 
answers varied from 1000-1400 kcal, and this equals to 35-50 kcal/kg in this patient of 28 kg. 
This is higher than the international guidelines propose (table 8 and 9), and higher than all the 
procedures at the regional departments of EDs in Norway, that varies from 10-30 kcal/kg in high-
risk groups. It should be noted that the patient in the case was already prescribed 1000 kcal, and 
presumably, this was taken into consideration when recommending initial feeding range. On the 
other hand, 1000-1400 kcal corresponds to the procedures and routines that recommend starting 
feeding with half food lists. International guidelines do also recommend feeding ranges in terms 
of kcal/day instead of kcal/kg, and these recommendations ranges from 600-1600 kcal/day (table 
9).  
 
In a study from northern America by Schwartz, Mansbach, Marion, Katzman, & Forman (2008), 
a wide variety in refeeding range of initial energy content in patients diagnosed with AN between 
physicians was found. The prescribed energy varied from 100-1500 kcal/day and solid foods, 
liquids, EN and PN were used. Only 37 % of the physicians followed protocols that were 
standardized. Fifteen percent prescribed supplements at admission for all patients, while others 
had an individual customization. The differences are not this big in our material, but we found 
that both procedures and recommendations from the physicians and RDs differ both in initial 
feeding and in supplements.  
 
Initial nutrition range is a topic of discussion in several studies. Some studies point out that 
recommended prescribed initial energy from guidelines may be too restrictive for many patients, 
and may contribute to initial weight loss (Golden et al., 2013; Whitelaw et al., 2010), which again 




outcome of the disease (Kohn, Madden, & Clarke, 2011; Sachs et al., 2015). Garber, Michihata, 
Hetnal, Shafer, and Moscicki (2012) found that 83 % of hospitalized AN patients starting at a diet 
of 1200 calories initially lost weight. A summary of studies done by Le Grange (2013), conclude 
that moderately malnourished (75-85 % of IBW) adolescents with AN could have a more 
aggressively nutrition program than proposed in the guidelines. They found that an initial feeding 
of 1764 kcal/day vs 1093 kcal/day resulted in faster weight gain and reduced hospitalization of 6 
days. Sachs et al. (2015) point out the importance of evaluating current guidelines and 
recommendations, and distinguish between moderate and severely malnourished patients. This 
association is also found in other studies, showing that patients with expected body weight of  > 
68 % could benefit from a more aggressively initial feeding than current guidelines suggest 
(Whitelaw et al., 2010).  
 
From the questionnaire, two responders pointed out that caution with carbohydrates could be 
necessary in the refeeding state of a patient at risk of RFS.  Other than that, responders answered 
that the patients should be feed with 45-60 % of energy coming from carbohydrates, 10-20 % 
from protein and 25-40 % from fat, as recommended by the Nordic Nutrition Recommendations 
(2012). Several studies have pointed out the role of carbohydrates in the contribution of RFS 
(Royal College of Psychiatrists, 2014). A study from O'Connor and Goldin (2011) emphasizes a 
reduced carbohydrate load in combination with a higher percentage of fat in the diet of a patient 
at risk of RFS. A reduced carbohydrate load will reduce the glucose load and therefore the release 
of insulin (O'Connor & Goldin, 2011). Kohn et al. (2011) recommends starting feeding with no 
more than 40 % of energy from carbohydrates. Only the procedure from RESSP (Bodø) 
recommends starting refeeding of (fast) carbohydrates with caution. 
 
5.2.1 Strengths and weaknesses of the questionnaire 
 
The questionnaire was sent out to 25 participants, naturally delimited by the number of 
physicians and RDs working at an ED unit. Two additional units with hospitalized patients (not 
regional departments) were included in this part of the thesis in order to get a higher number of 
responders, but still the response rate was low. The low response rate of 52 % is a weakness and a 




However, a trend in the answers received can be seen, and some of it can be compared to exciting 
literature within this field.  
 
The questionnaire itself has several weaknesses. In some of the questions the informants 
answered more than requested (ticked several options), and therefore it was necessary to remove 
their answer on these specific questions from the analysis. Some of the responders also 
misunderstood some questions. Physicians and RDs in the same unit had different answers on 
questions regarding procedures. This may be due to both that the physicians and RDs asked not 
are aware that their department has a procedure to identify and/or treat patients at risk of RFS or 
misunderstanding of the question.  
 
The questionnaire also had some questions that have given little or no information, and these 
questions could therefore have been left out when making the questionnaire. Other and more 
precise questions could have been asked to obtain more informative answers. However, a longer 
questionnaire may have resulted in an even lower response rate. Even though a preliminary test 
of the questionnaire was carried out on a few RDs, the outcome of the questionnaire was difficult 
to predict. 
 
5.3  “Grunnmeny” and “Halv grunnmeny” 
 
The results from the analysis of the “Grunnmeny” and “Halv grunnmeny” at RASP are results of 
a four-week menu. The challenge is still what is actually eaten by the individual patients, but this 
is not evaluated here. 
 
The amount of calories given the patients during refeeding does not always correlate with the rate 
of weight gain, and the amount of energy needed for weight gain vary between 1800-4500 
kcal/day in AN patients (Mehler et al., 2010). Before refeeding, the AN patient is in a hypo 
metabolic state, which means that weight gain could be met even though the energy intake is 
below the expected energy requirements. On the other hand, there may also be an extra increase 
in the resting metabolic rate in AN patients during weight gain, increasing the requirements of 
calories up to 70-80 kcal/kg/day during this hyper metabolic phase. This specially occurs when 




In the “Grunnmeny” at RASP the amount of calories are higher than The Norwegian Directorate 
of Health recommend for healthy women aged 18-30. However, the experiences from RASP have 
been that this amount of energy has been too low for many patients (especially for adolescents), 
and “Grunnmeny” has therefore been increased to meet the energy needs for these patients. For 
weight maintenance, Marzola, Nasser, Hashim, Shih, and Kaye (2013) found that weight-restored 
patients with AN often require more calories than sex-, age-, weight-, and height-matched control 
subjects (50-60 kcal/kg/day vs 20-40 kcal/kg/day) to maintain weight for a certain period or all 
life through, due to slow normalisation of neuroendocrine processes. Most patients normalize 
metabolism after 3 to 6 months of weight maintenance (Zipfel et al., 2015). During refeeding of 
these patients, this should be taken into consideration. 
 
The analysis of the basic reference menu at RASP showed that kilocalories in the weighted 
dinner portions varied from 234-662 kcal, which is a difference of 428 kcal. The mean energy 
content was 480 kcal (SD 100). However, the dinner that was low in calories was a mistake from 
the kitchen that special day due to misunderstanding of the recipe. The dinner that was second 
lowest in calories was at 339 kcal, and may be a more accurate estimate of the differences in 
calories between the dinner portions. Even if one dinner was very low in calories, the average 
energy content through the four-week dinner menu was within the recommendations, implying 
that, if such mistakes do not happen often, it may not be of crucial relevance for the patients` 
weight gain.  
 
If the patients choose porridge and cereals for breakfast and evening meal, the calorie content is 
lower than if they choose bread as an option. The calories in the bread meals vary depending on 
which spread and topping they use, but when possible, the RDs experience is that the patients 
would choose the options that are low in calories. As an example; a meal with two slices of 
bread, one portion of both turkey and cream cheese will give a total of 52 kcal, compared to if the 
patient would choose brown goat cheese and white cheese the calorie content would have a total 
of 135 kcal, only with this topping (not included the bread and butter/margarine). Therefore, in 
one meal with bread, the patient’s choice of topping could vary with at least 83 kcal. To prevent 
that the patients could choose low calorie options for each meal, different types of spread and 





The distribution of macronutrients (table 19) is within the recommendations (Helsedirektoratet, 
2015), with protein in the upper levels and carbohydrates in the lower recommendation range. As 
discussed with the procedures and questionnaire, the recommendations presented in the literature 
with reduced carbohydrate intake are not a part of the procedure at RASP. However, the basic 
reference menu focuses on enough energy, enough protein and enough micronutrients, and to 
achieve this within the recommended energy contents, E % of carbohydrates may automatically 
decrease. In addition, even if not clarified in procedures, the “Halv grunnmeny” excludes sugary 
drinks for the benefit of milk products high in minerals (especially phosphorus) and protein.   
 
Recommended dietary fiber intake is 25-35 g/day (Helsedirektoratet, 2015). In “Halv 
grunnmeny” the recommendations of fiber is not covered, while in “Grunnmeny” the 
recommendations are exceeded with an average of an additional 10 g/day. This is a lot, 
considering that these patients often have digestive problems, feeling full and discomfort after a 
meal (Zipfel et al., 2006). Fiber may increase this discomfort and increase the satiety after a meal, 
which could make it even more difficult to stick to the diet plan and obtain a favourable weight 
gain. When analysing the “Grunnmeny” in “Kostholdsplanleggeren”, bread with 50-75 % 
wholegrain was used. The bread they use at RASP may vary, and will differ between days and 
meals, but the RDs recommend using bread with about 50 % wholegrain. The high fiber content 
found in this analysis may be falsely high due to that wholegrain bread was used more often as an 
option in the “Kostholdsplanleggeren” than bread with lower fiber content. However, the RDs 
suspect that high fiber and wholegrain bread are used more today than initially recommended, 
due to the general opinion that more fiber is healthy.  
 
“Grunnmeny” and “Halv grunnmeny” cover most of the recommendations of micronutrients and 
minerals recommended by the Norwegian Directorate of Health, except from iron in 
“Grunnmeny” and phosphate, iron and potassium in “Halv grunnmeny” (Helsedirektoratet, 
2015). In “Halv grunnmeny”, milk is the only beverage of option (besides water) for every meal.  
This is to secure the patients’ requirements for proteins, calcium and phosphorus despite that their 
diets are lower than recommended in calories. A diet higher in protein to cover the nutritional 
requirements of nitrogen may be favourable when eating a low calorie diet, as the “Halv 
grunnmeny” is (Fuentebella & Kerner, 2009). Calcium prescribed is well above the 




addition to this will not have any beneficial effects, even if it is recommended by the general 
procedure for the hospitalized patients. Multivitamin and mineral is recommended as a 
supplement for all individuals consuming a diet lower than 1500 kcal (Helsedirektoratet, 2015), 
as the “Halv grunnmeny”.  
 
The Norwegian Directorate of Health recommend to keep the sodium intake below 2.3 g/day, 
equals to 6 g salt/day (Helsedirektoratet, 2015), but a lower intake might be even more 
favourable. The average prescribed salt intake at in “Grunnmeny” exceeds the recommended 
levels, with an average excess of about 700 mg sodium/day, or nearly an excess of 2 g salt/day. 
Optional salt at the table is not included in the analyses, so the levels may be even higher. As 
described in chapter 2.1.2, a low sodium diet is recommended for patients at risk of RFS. 
However, the average salt prescribed in “Grunnmeny” at RASP are lower than the average intake 
in Norway, which is 10 g salt/day (Helsedirektoratet, 2015). The high salt content found in this 
analysis may be due to that bread available in “Kostholdsplanleggeren” contains more salt than 
the bread served at RASP. Even if not investigated, the homemade bread at RASP served to 
lunch is likely to contain less salt than bread available in “Kostholdsplanleggeren”.  
 
During the procedure collection, some of the dietary lists at the other regional departments were 
collected as well. The general observation was that the other dietary lists were lower in energy 
than “Grunnmeny”, with about 500 kcal. This again means that half of the dietary lists that they 
have at the other departments (which they report to be the dietary lists for patients at risk of RFS) 
will be lower in energy than “Halv grunnmeny”. If this difference affects the patients in a great 
extent is not investigated, but a difference of 500 kcal/day could result in a difference of 0.5 kg 
weight gain/week (The National Institute for Health and Care Excellence 2004). At RASP they 
recommend a weight gain each week 1-1.5 kg, for inpatients and it is not discussed or evaluated 
here how much the reduction of underweight are prescribed in other departments. As discussed, 
weight gain is crucial in the treatment of AN patients, and normalization of food intake, reduced 
hospitalization and higher weight at discharge may influence recovery and lower risk of relapse 
in the patients. In addition, the focus on phosphorus rich foods and protein in the half dietary lists 
at the other departments are not investigated, and the awareness may not be the same as it is at 
RASP.  If the dietary lists at other departments than RASP are developed by RDs are unclear and 




5.3.1 Strengths and weaknesses of the basic reference menu 
 
Only the ingredients of the dinner portions were actually weighed. The four-week dinner rollover 
menu was also only weighed once, and several weighing’s could have been more preferable to 
find the average. However, it is assumed that the average of four weeks of weighing would give a 
reasonable good estimate of the average nutrient content, and making this a fairly good estimate 
of the reality during a hospitalization period at RASP. At least if the patient eat the dinner menu, 
but some patients use nutritional drinks that would complicate these calculations of micronutrient 
content even more. This assumption is also made according to the analysis of the whole four-
week menu, because every patient is different and choose different foods, so even if the whole 
menu had been weighed, this menu would have been representative for only one patient. When 
the basic reference food menu at RASP were analysed, it was taken into consideration that some 
of the meal options are more likely to be chosen by the patients than others. Most patients would 
rather choose low fat or low calorie options when possible, whole fruits rather than juice and 
yoghurt more often than the department’s dessert. 
 
Considering the weighing of the dinner portions, there were some limitations to consider. First, 
some of the meals consisted of different food types, where the sauce was poured over the whole 
plate. In such dishes, it was difficult to separate the food on the plate and to do exact weighing of 
each component. Other limitations were that some of the dinner plates were weighed the day after 
the meal was prepared, which could have affected the true weight of the food. The fact that some 
of the dinner portions also were weighed with a different scale could have affected the results. 
 
A limitation is also linked to the use of “Kostholdsplanleggeren” as an analyse program. In 
“Kostholdsplanleggeren” it is possible to look up 1543 ingredients and dishes, which includes the 
contents of 38 different nutrients (Matportalen, 2016). This was a limitation when calculating the 
nutrient content of the four-week rollover menu. Not all preferred food choices were available, 
and sometimes only the best available similar option could be chosen. The food choices in 
“Kostholdsplanleggeren” are updated once a year with new foods from “Matvaretabellen” 
(Matportalen, 2016), which may contribute to that not all preferred food choices is available. 
Other analyse programs may have been more favourable to use, but “Kostholdsplanleggeren” was 




correspond quite good with the calculations of nutrient content and energy performed formerly by 
the RDs at RASP. 
 
 
5.4  Future research 
 
A proposed suggestion for further research is to look at true incidences of RFS in EDs through 
medical records, and to differentiate between hypophosphatemia to a certain limit and to a full-
blown RFS. This implies that a clear definition of RFS is determined. This would also be time 
consuming and difficult when a clear diagnosis of RFS exists, but this could probably be a better 
approach to be able to recommend something specific for this particular patient group. To 
achieve enough material and validity or reproducibility, this group would need to be investigated 
for several years. International studies have looked at cases of hypophosphatemia, and this could 
have been done (Brown, Sabel, Gaudiani, & Mehler, 2015; Ornstein et al., 2003), however, 
hypophosphatemia is not alone a predictor for whether patients develop RFS or not. The goal in 
this thesis was to study the procedures themselves and the subjective opinions from the 
physicians and RDs. Further research could be to investigate these procedures and if they are 
followed. 
 
Another research option for the future is to investigate how much of the food in the dietary list 
the patients actually eat. In this thesis the amount of food prescribed has been evaluated, and 
whether these lists are within the recommendations and could be favourable for patients at risk of 
RFS. What the patients actually eat is not investigated. A study where the portions were weighed 
before it was served to the patients, and then weighing what is left afterwards could give a good 
estimate of what a patient actually eat during a day.  Still, there would be challenges to what the 
patient actually would digest and absorb due to for example spitting of food and vomiting that is 







5.5  Conclusion 
 
Of the six regional departments of EDs in Norway, three of them (RASP (Oslo), RKSF 
(Levanger) and RESSP (Bodø)) have specific procedures to detect and treat patients at risk of 
RFS. Considering that these departments hospitalize patients that in the literature are defined as at 
risk of RFS, a procedure ought to have been present in every department treating patients with 
AN. The collaboration of a common procedure between the different regional departments of 
EDs in Norway could usefully be enhanced. The existing procedures vary, and should be 
evaluated compared to new literature, but more research is needed to give satisfying knowledge 
about the risk of RFS in AN patients, and about identification, treatment and monitoring of these 
patients.  
 
Due to the low response rate of 52 % to our questionnaire, the results of the survey are uncertain. 
However, the questionnaire detected that there are some uncertainties between the physicians and 
RDs of the definition of RFS. Hypophosphatemia (<0.5 mmol/L), cardiac arrhythmias, peripheral 
oedemas, pulmonary oedemas and heart failure are the most accepted symptoms.  
 
“Grunnmeny” is the basic reference menu at RASP. The energy content and the distribution of 
energy yielding macronutrients in the dinner portions are as calculated by the RDs, but a 
clarification within the recipes ought to be made to eliminate the chances for the milieu therapists 
and kitchen personnel to make mistakes regarding portion sizes.  
 
The energy prescribed in “Halv grunnmeny” is higher than most of the international guidelines 
for initial refeeding of patients at risk of RFS, equivalent to 35 kcal/kg body weight in a patient of 
40 kg, which is likely to be the weight of a patient at an ED unit. However, individual 
customization is made, and the “Halv grunnmeny” makes an important frame for and is a good 
guidance for the milieu therapists that serve the patients during the nutritional rehabilitation at 
RASP.  
 
The analysis shows that iron supplementation should be assessed in both of the basic reference 
menus. The importance of supplementation of omega 3 and vitamin D was confirmed during this 
analysis. A supplementation of multivitamins in addition to the “Grunnmeny” is not necessary 




1500 kcal, as the content prescribed in “Halv grunnmeny”. Calcium supplementation may also be 
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7.1  Appendix 1 
 
 
Spørreundersøkelse til leger og kliniske ernæringsfysiologer ved 
spesialavdelinger for spiseforstyrrelser om reernæringssyndrom 
 
Kjønn: ☐Mann ☐Kvinne            Alder:     Arbeidssted:      Yrkestittel:       
 
Hvor lenge har du jobbet med spiseforstyrrelser?      år 
 
Opplever du at du har tilstrekkelig kunnskap om risiko for reernæringssyndrom og hva 
reernæringssyndrom er?  
☐Ja, jeg kunne satt i gang behandling og føler meg trygg på hva som må gjøres 









4. Det er ikke entydig i litteraturen hva som defineres som reernæringssyndrom; Hva 
mener du skal til for å kalle noe et reernæringssyndrom? Kryss av de symptomene og 
verdiene du mener bør være til stede/er de viktigste. 
 
☐fosfat<0,85mmol/L  ☐perifere ødemer 
☐fosfat<0,50mmol/L  ☐wernicke-korsakoffs syndrom 
☐fosfat<0,32mmol/L  ☐hypervolemi    
☐kalium<3,5mmol/L  ☐lungeødem 
☐kalium<2,5mmol/L   ☐metabolsk acidose 
☐magnesium<0,7mmol/L ☐koma 
☐magnesium<0,5mmol/L ☐ataksi 
☐kramper   ☐hjertesvikt/infarkt      
☐hjertearytmier   ☐anemi 
☐rabdomyolyse   ☐respirasjonssvikt 
☐enchefalopati    ☐Hypoglykemi 
☐Andre:       ☐Vet ikke, må slå opp for å få eksakte verdier/symptomer 
      
Eventuelle kommentarer:       
 
5. Har dere på din arbeidsplass skriftlige prosedyrer som er spesifikt utviklet for å 
identifisere og behandle pasienter i risiko for reernæringssyndrom?  
☐Ja  
☐Nei  





a. Hvis ja; hvilke prosedyrer? Beskriv:      
 
Eventuelle kommentarer:       
 
 
6. Har dere på din arbeidsplass skriftlige prosedyrer som vil identifisere og beskrive 
behandling av pasienter som er i risiko for reernæringssyndrom selv om prosedyren 
ikke spesifikt er laget for dette (dette inkluderer prosedyrer for somatisk undersøkelse, 
blodprøver, tilskudd av vitaminer og mineraler, monitorering, energi og væskemengde ved 
oppstart av ernæring, som brukes generelt for alle pasientene)? 
☐Ja  
☐Nei  
☐Vet ikke  
 
a. Hvis ja; hvilke prosedyrer? Beskriv:      
b. Hvis nei, hva gjøres? Beskriv:       
 
Eventuelle kommentarer:      
 





Eventuelle kommentarer:       
 
8. Har du sett pasienter med symptomer eller labverdier utenfor referanseverdiene 
(begynnende reernæringssyndrom) som følge av oppstart av reernæring?  
  ☐Ja  
  ☐Nei 
 
a. Hvis ja; Hvor mange pasienter har du sett med slike symptomer (anslå)?  
i.Totalt:        stk 
ii. Det siste året:      stk 
 
b. Hvis ja; Hva er de vanligste symptomene eller labverdiene du har sett(nevn de tre 
hyppigste)? 
Svar:       
 
c. Hvis ja; Ble denne/disse pasientene ernært via…(fyll inn antall pasienter som ble ernært 
via de ulike rutene):  
Vanlig mat:         stk 
Sondeernæring:        stk 
Intravenøs ernæring       stk 
En kombinasjon av disse:       stk 
Husker ikke/vet ikke:                  stk 
 




9. Har du på din arbeidsplass sett pasienter som har fullt utviklet reernæringssyndrom? 
☐Ja  
☐Nei 
a. Hvis ja; Hvor mange pasienter har du sett med reernæringssyndrom? 
i. totalt:               stk 
ii. det siste året:      stk 
 
b. Hvis ja; Ble denne/disse pasientene ernært via…(fyll inn antall pasienter som ble ernært 
via de ulike rutene):  
Vanlig mat:         stk 
Sondeernæring:        stk 
Intravenøs ernæring:       stk 
En kombinasjon av disse:       stk 
Husker ikke/vet ikke:                  stk 
 
Eventuelle kommentarer:       
 
10. Opplever du at kunnskapen om reernæringssyndrom og risikoen for dette er 




☐I varierende grad 
☐Vet ikke 
b. KEFer:  
☐Ja  
☐Nei 
☐I varierende grad 
☐Vet ikke 
c. Annet helsepersonell:  
☐Ja  
☐Nei 
☐I varierende grad 
☐Vet ikke  
 
 
11. Opplever du at reernæringssyndrom eller lignende komplikasjoner er et hyppig 





12. Opplever dere at pasienter går ned i vekt etter innleggelse selv om de følger oppsatt 
reernæringsplan? 
☐Ja, ofte 






13. Hva er gjennomsnittlig innleggelsestid for pasienter på din arbeidsplass? 
 
Svar:       
 
Videre følger en case, og spørsmål knyttet opp mot denne; 
 
Kvinne 19 år, spiseforstyrrelser siden 14- års alder. Restriktiv anoreksi med oppkast, 
aktivitetstrang og misbruk av laksativer. Løs avføring/diare. Veier 28kg og har en BMI på 
12,6kg/m2 ved innkomst. Får i seg ca 1000kcal/dag via sonde og mat.  
 
Du skal gjøre en vurdering av denne pasienten ved innleggelse. 
 
14. Hvilke blodprøver ville du anbefalt å ta/rekvirert på denne pasienten (velg ut de 
5viktigste)? 
☐Hemoglobin   ☐Glukose  ☐Leukocytter    ☐Trombocytter 
☐Natrium   ☐Kalium  ☐Cystatin c   ☐CRP 
☐Kreatinin   ☐Kalsium ☐Albumin   ☐TSH 
☐Fosfat   ☐Alat  ☐Klorid   ☐Vit d 
☐Amylase   ☐Lipase ☐Homocystein  ☐Magnesium  
☐Asat    ☐Bilirubin ☐Ferritin   ☐Kobalamin 
☐Hba1c   ☐Kolesterol ☐Triglyserider  ☐Karbamid 
 
15. Hvor mye energi/kilokalorier ville du gitt første dag?  
Svar:       
 




☐en kombinasjon av disse 
 
Eventuelle kommentarer:       
 
17. Hvordan ville du prostenvis fordelt makronæringsstoffer (karbohydrater, fett og 
proteiner) de første dagene? 
Svar:       
☐Vet ikke, må undersøke for å finne svar på dette 
 
18. Hvilke tilskudd du ville gitt, og på hvilken måte(tidspunkt og tilførselsvei) de første 3 
dagene?: 
 
 Tidspunkt Tilførselsvei 





Tiamin         ☐                  ☐   ☐           ☐        ☐ 
Fosfat         ☐                  ☐   ☐           ☐        ☐ 
Kalium         ☐                  ☐   ☐           ☐        ☐ 




Omega 3         ☐                  ☐   ☐           ☐        ☐ 
Multivitamin         ☐                  ☐   ☐           ☐        ☐ 
Vit D         ☐                  ☐   ☐           ☐        ☐ 
Kalsium         ☐                  ☐   ☐           ☐        ☐ 
Kopper         ☐                  ☐   ☐           ☐        ☐ 
Selen         ☐                  ☐   ☐           ☐        ☐ 
Sink         ☐                  ☐   ☐           ☐        ☐ 
Jern         ☐                  ☐   ☐           ☐        ☐ 
B-vitaminer         ☐                  ☐   ☐           ☐        ☐ 
Vit C         ☐                  ☐   ☐           ☐        ☐ 
Andre:              ☐                  ☐   ☐           ☐        ☐ 
Andre:              ☐                  ☐   ☐           ☐        ☐ 
 
Eventuelle kommentarer:       
 
19. Hvor ofte ville du anbefalt å monitorere pasienten (blodprøver og somatisk 
undersøkelse) de første to ukene?  
☐Flere ganger daglig  
☐Daglig  




Eventuelle kommentarer:       
 
20. Hvor lenge ville du anbefalt å monitorere (blodprøver og somatisk undersøkelse) 
pasienten utover dette?  
☐Er ikke nødvendig å monitorere pasienten videre etter dette  
☐Til prøvene er stabile 
☐1 uke  
☐2 uker  
☐Lengre enn 2 uker 
 
Eventuelle kommentarer:       
 
 
Har du eventuelle andre kommentarer knyttet til spørreskjema eller reernæringssyndrom kan det 
skrives her:       
 









7.2 Appendix 2 
 
Blood tests and supplements 
 
The blood tests presented in table 24 are not exclusively for patients at risk of RFS, but blood test 
that are analysed in all patients hospitalized at a regional department of eating disorders. The 
answers from the blood samples could contribute to the evaluation whether a patient is at risk of 
developing RFS, and is an important tool in this identification.  
 
 




































































































 SR     X  
 Hematocrit X      
 Leukocytes X X X X X  
 Thrombocytes X X X X X  
 Erythrocytes X      
 Neutrophils  X  X   
 Eosinophils X      
 Lymphocytes    X   
 Monocytes  X     
 MCV  X X  X   
 MCH X      
 Differential cell counting   X  X  
 Ferritin X X  X X  
 Vitamin B12 X X  X X  
 Methylmalonate     X  
 Folate X X  X X  
 Homocysteine     X  
 PT-INR X X     




Electrolytes Sodium X X X X X  
 Potassium X X X X X  
 Calcium total X    X  
 Calcium ionized X   X   
 Magnesium X X X X X  
 Phosphate X X X X X  
 Chloride X X X X X  
 Osmolality X      
Metabolites Bilirubin X   X   
 Urea/carbamide X    X  
 Creatinine X X X X X  
Carbohydrates Glucose X X  X X  
 Hba1c     X  
Enzymes ALAT X   X X  
 GT X    X  
 LD X      
 Creatine kinase X      
 ALP X   X X  
 Amylase X    X  
 Lipase     X  
 ASAT    X X  
 Cystatin C     X  
Blod gas Acid/base X X  X X  
Lipids Cholesterol total X    X  
 HDL X    X  
 LDL     X  
 Triglycerides X    X  
Proteins Albumin X X  X X  
 CRP X    X  
Hormones TSH X X X X X  
 FT4 X X X X X  
 FT3 X    X  
 PTH X      
 Prolactin  X   X  
 FSH  X     
 Estradiol  X     
 LH  X     
Vitamins 25OHvitD X X   X  
 1.25OH2vitD X      
SR: sedimentation rate, MCV: middle cell volume, MCH: mean cell hemoglobin, PR-INR: prothrombine-
international normalized ratio, ALAT: alanine aminotransferase, ASAT: aspartate aminotransferase, GT: gamma-
glutamyltransferase, LD: lactate dehydrogenase, ALP: alkaline phosphatase, HDL: high density lipoprotein, LDL: 
low density lipoprotein, CRP: C-reactive protein, TSH: thyroid stimulating hormone, FT4/FT3: free thyroxin, PTH: 






Table 25 gives an overview of which supplements all patients receives during hospitalization at 
the different regional departments. The supplements are given independently of blood test and 
blood levels, and are supplements to the dietary lists.  
 
 
Table 25 Supplementation of all patients at each regional department  
 Oslo Bergen Stjørdal Levanger Bodø Tromsø 
Calcium 500mg with 
vitamin D* 
**    ** 
Omega 3 2 capsules/day 
or tran 
** 1 capsule/day 1 
capsule/day 
Yes ** 
Vitamin D  **    ** 
Multivitamins Nycoplus 1x1* ** 1/day 1/day Yes ** 
*vitamin D max 20ug from supplements/day 
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3 brødskiver med margarin + pålegg  
eller Grøt (mand-fred) 
eller Frokostblanding med melk 
 
1 glass melk  + 1 glass juice 
 
kl 10.30:Mellommåltid: individuelt 
 
Lunsj  
Salat og rundstykke (dressing eller margarin) (hverdager) 
eller 3 brødskiver + 1 knekkebrød med margarin + pålegg  
 
1 glass melk  + 1 glass juice 
 






1 glass juice/saft/melk 
 
1 porsjon dessert eller 1 stk yoghurt (150 ml) 
 
kl 19.00: Mellommåltid: Individuelt 
 
Kvelds  
3 brødskiver med margarin + pålegg  
eller Frokostblanding med melk 
 
1 glass melk  + 1 glass juice 
 
 








Til 3 skiver: 1,5 pk margarin 
 
 
Til 3 skiver og 1 kn.brød: 
2 pk margarin 
Til salat: 1 pk margarin eller 1 
dressing  
 






7.5 Appendix 5 
 




1½  brødskiver med margarin + pålegg  
eller ½ porsjon grøt (mand-fred) 
eller ½ porsjon frokostblanding med melk 
 
1 glass melk  
 




½ porsjon salat og ½ rundstykke m/marg el dressing (hverdager) 
eller 2 brødskiver med margarin + pålegg  
 
1 glass melk  
 




½ porsjon avdelingens middag 
 
1 glass juice/saft/melk 
 




1½ brødskive med margarin + pålegg  
eller ½ porsjon frokostblanding med melk 
 
1 glass melk  
 
 











Til 2 skiver: 1 pk margarin 
Til salat: 1 pk dressing eller 1 pk 
margarin 
 
Til 1,5 skive: 1 pakke 
margarin 
 
 
